Home Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

FPG #8: Alternative Treatments in Psychiatry
FPG #7: Critical Care in Neurology
Free Medical Books

  Parkinson's Disease

  Free Subscription


Articles published in Mov Disord

Retrieve available abstracts of 660 articles:
HTML format
Text format



Single Articles


    January 2012
  1. BOELMANS K , Holst B, Hackius M, Finsterbusch J, et al
    Brain iron deposition fingerprints in Parkinson's disease and progressive supranuclear palsy.
    Mov Disord. 2012 Jan 30. doi: 10.1002/mds.24926.
    PubMed     Text format     Related articles    Abstract available



  2. DI GIACOPO R , Fasano A, Quaranta D, Marca GD, et al
    Rivastigmine as alternative treatment for refractory REM behavior disorder in Parkinson's disease.
    Mov Disord. 2012 Jan 30. doi: 10.1002/mds.24909.
    PubMed     Text format     Related articles    Abstract available



  3. FURUSAWA Y , Mukai Y, Kobayashi Y, Sakamoto T, et al
    Role of the external oblique muscle in upper camptocormia for patients with Parkinson's disease.
    Mov Disord. 2012 Jan 30. doi: 10.1002/mds.24930.
    PubMed     Text format     Related articles   



  4. GUELLA I , Solda G, Cilia R, Pezzoli G, et al
    The Asp620asn mutation in VPS35 is not a common cause of familial Parkinson's disease.
    Mov Disord. 2012 Jan 25. doi: 10.1002/mds.24927.
    PubMed     Text format     Related articles   



  5. LITVAN I , Goldman JG, Troster AI, Schmand BA, et al
    Diagnostic criteria for mild cognitive impairment in Parkinson's disease: Movement Disorder Society Task Force guidelines.
    Mov Disord. 2012 Jan 24. doi: 10.1002/mds.24893.
    PubMed     Text format     Related articles    Abstract available



  6. MONTGOMERY EB JR
    Subthalamic nucleus neuronal firing rates in Parkinson's disease.
    Mov Disord. 2012 Jan 20. doi: 10.1002/mds.24901.
    PubMed     Text format     Related articles   



  7. REMPLE MS , Bradenham CH, Kao CC, Charles PD, et al
    Changes in neuronal firing rate in the subthalamic nucleus with Parkinson's disease.
    Mov Disord. 2012 Jan 19. doi: 10.1002/mds.24899.
    PubMed     Text format     Related articles   



  8. RICHTER J , Appenzeller S, Ammerpohl O, Deuschl G, et al
    No evidence for differential methylation of alpha-synuclein in leukocyte DNA of Parkinson's Disease patients.
    Mov Disord. 2012 Jan 19. doi: 10.1002/mds.24907.
    PubMed     Text format     Related articles   



  9. SIDEROWF A , Jennings D, Eberly S, Oakes D, et al
    Impaired olfaction and other prodromal features in the Parkinson At-Risk Syndrome study.
    Mov Disord. 2012 Jan 11. doi: 10.1002/mds.24892.
    PubMed     Text format     Related articles    Abstract available



  10. LOBSIEN E , Schreiner S, Plotkin M, Kupsch A, et al
    No correlation of substantia nigra echogenicity and nigrostriatal degradation in Parkinson's disease.
    Mov Disord. 2012 Jan 11. doi: 10.1002/mds.24070.
    PubMed     Text format     Related articles    Abstract available



  11. STARKSTEIN SE
    Apathy in parkinson's disease: Diagnostic and etiological dilemmas.
    Mov Disord. 2012 Jan 11. doi: 10.1002/mds.24061.
    PubMed     Text format     Related articles    Abstract available



  12. BROEN MP , Braaksma MM, Patijn J, Weber WE, et al
    Prevalence of pain in Parkinson's disease: A systematic review using the modified QUADAS tool.
    Mov Disord. 2012 Jan 9. doi: 10.1002/mds.24054.
    PubMed     Text format     Related articles    Abstract available



  13. MICHELAKAKIS H , Xiromerisiou G, Dardiotis E, Bozi M, et al
    Evidence of an association between the scavenger receptor class B member 2 gene and Parkinson's disease.
    Mov Disord. 2012 Jan 5. doi: 10.1002/mds.24886.
    PubMed     Text format     Related articles    Abstract available



  14. MELAMED E , Poewe W
    Taking sides: Is handedness involved in motor asymmetry of Parkinson's disease?
    Mov Disord. 2012 Jan 5. doi: 10.1002/mds.24048.
    PubMed     Text format     Related articles   



  15. STERN MB , Lang A, Poewe W
    Toward a redefinition of Parkinson's disease.
    Mov Disord. 2012;27:54-60.
    PubMed     Text format     Related articles   



  16. BROOKS DJ
    Can imaging separate multiple system atrophy from Parkinson's disease?
    Mov Disord. 2012;27:3-5.
    PubMed     Text format     Related articles   



    December 2011
  17. SUZUKI M , Yoshioka M, Hashimoto M, Murakami M, et al
    25-hydroxyvitamin D, vitamin D receptor gene polymorphisms, and severity of Parkinson's disease.
    Mov Disord. 2011 Dec 31. doi: 10.1002/mds.24016.
    PubMed     Text format     Related articles    Abstract available



  18. LOUIS ED , Huey ED, Gerbin M, Viner AS, et al
    Apathy in essential tremor, dystonia, and parkinson's disease: A comparison with normal controls.
    Mov Disord. 2011 Dec 19. doi: 10.1002/mds.24049.
    PubMed     Text format     Related articles    Abstract available



  19. VAN DER HOORN A , Hof AL, Leenders KL, de Jong BM, et al
    Narrowing wide-field optic flow affects treadmill gait in left-sided Parkinson's disease.
    Mov Disord. 2011 Dec 15. doi: 10.1002/mds.24011.
    PubMed     Text format     Related articles   



  20. SETO-SALVIA N , Pagonabarraga J, Houlden H, Pascual-Sedano B, et al
    Glucocerebrosidase mutations confer a greater risk of dementia during Parkinson's disease course.
    Mov Disord. 2011 Dec 15. doi: 10.1002/mds.24045.
    PubMed     Text format     Related articles    Abstract available



  21. CUBO E , Trejo Gabriel-Galan JM, Seco Martinez J, Rioja Alcubilla C, et al
    Comparison of office-based versus home web-based clinical assessments for Parkinson's disease.
    Mov Disord. 2011 Dec 15. doi: 10.1002/mds.24028.
    PubMed     Text format     Related articles    Abstract available



  22. BURN DJ , Landau S, Hindle JV, Samuel M, et al
    Parkinson's disease motor subtypes and mood.
    Mov Disord. 2011 Dec 11. doi: 10.1002/mds.24041.
    PubMed     Text format     Related articles    Abstract available



  23. BARTON B , Grabli D, Bernard B, Czernecki V, et al
    Clinical validation of movement disorder society-recommended diagnostic criteria for Parkinson's disease with dementia.
    Mov Disord. 2011 Dec 9. doi: 10.1002/mds.24059.
    PubMed     Text format     Related articles    Abstract available



  24. OKUN MS
    Parkinson's disease patients cannot get their dopamine replacement: The 8-sinemet limit.
    Mov Disord. 2011 Dec 9. doi: 10.1002/mds.24038.
    PubMed     Text format     Related articles   



  25. KIM JS , Cho JW, Shin H, Lee WY, et al
    A Korean Parkinson's disease family with the LRRK2 p.Tyr1699Cys mutation showing clinical heterogeneity.
    Mov Disord. 2011 Dec 9. doi: 10.1002/mds.24033.
    PubMed     Text format     Related articles    Abstract available



  26. PERON J , Dondaine T, Le Jeune F, Grandjean D, et al
    Emotional processing in Parkinson's disease: A systematic review.
    Mov Disord. 2011 Dec 9. doi: 10.1002/mds.24025.
    PubMed     Text format     Related articles    Abstract available



  27. NOYCE AJ , Silveira-Moriyama L, Gilpin P, Ling H, et al
    Severe dysphagia as a presentation of Parkinson's disease.
    Mov Disord. 2011 Dec 9. doi: 10.1002/mds.24006.
    PubMed     Text format     Related articles   



  28. LEES A , Fahn S, Eggert KM, Jankovic J, et al
    Perampanel, an AMPA antagonist, Found to have no benefit in reducing "Off" time in Parkinson's disease.
    Mov Disord. 2011 Dec 9. doi: 10.1002/mds.23983.
    PubMed     Text format     Related articles    Abstract available



  29. WEINTRAUB D , Mamikonyan E, Papay K, Shea JA, et al
    Questionnaire for impulsive-compulsive disorders in Parkinson's Disease-Rating Scale.
    Mov Disord. 2011 Dec 1. doi: 10.1002/mds.24023.
    PubMed     Text format     Related articles    Abstract available



  30. FASANO A , Matteo AD, Vitale C, Squintani G, et al
    Reversible Pisa syndrome in patients with Parkinson's disease on rasagiline therapy.
    Mov Disord. 2011;26:2578-80.
    PubMed     Text format     Related articles   



  31. DANIELS C , Krack P, Volkmann J, Raethjen J, et al
    Is improvement in the quality of life after subthalamic nucleus stimulation in Parkinson's disease predictable?
    Mov Disord. 2011;26:2516-21.
    PubMed     Text format     Related articles    Abstract available



  32. BARONE P , Aarsland D, Burn D, Emre M, et al
    Cognitive impairment in nondemented Parkinson's disease.
    Mov Disord. 2011;26:2483-95.
    PubMed     Text format     Related articles    Abstract available



  33. VOLKMANN J
    The Wilson films - Parkinson's disease.
    Mov Disord. 2011;26:2475-6.
    PubMed     Text format     Related articles    Abstract available



    November 2011
  34. MONTGOMERY EB JR , Huang H, Walker HC, Guthrie BL, et al
    High-frequency deep brain stimulation of the putamen improves bradykinesia in Parkinson's disease.
    Mov Disord. 2011 Nov 23. doi: 10.1002/mds.23998.
    PubMed     Text format     Related articles   



  35. ASAHI T , Inoue Y, Hayashi N, Araki K, et al
    Alleviation of dysphagia after deep brain stimulation: results from a Parkinson's disease patient.
    Mov Disord. 2011 Nov 23. doi: 10.1002/mds.23899.
    PubMed     Text format     Related articles   



  36. SCHMITZ-HUBSCH T , Eckert O, Schlegel U, Klockgether T, et al
    Instability of syllable repetition in patients with spinocerebellar ataxia and Parkinson's disease.
    Mov Disord. 2011 Nov 22. doi: 10.1002/mds.24030.
    PubMed     Text format     Related articles    Abstract available



  37. WINDER-RHODES SE , Garcia-Reitbock P, Ban M, Evans JR, et al
    Genetic and pathological links between Parkinson's disease and the lysosomal disorder Sanfilippo syndrome.
    Mov Disord. 2011 Nov 18. doi: 10.1002/mds.24029.
    PubMed     Text format     Related articles    Abstract available



  38. PERJU-DUMBRAVA LD , Kovacs GG, Pirker S, Jellinger K, et al
    Dopamine transporter imaging in autopsy-confirmed Parkinson's disease and multiple system atrophy.
    Mov Disord. 2011 Nov 18. doi: 10.1002/mds.24000.
    PubMed     Text format     Related articles    Abstract available



  39. SEARLES NIELSEN S , Gallagher LG, Lundin JI, Longstreth WT Jr, et al
    Environmental tobacco smoke and Parkinson's disease.
    Mov Disord. 2011 Nov 16. doi: 10.1002/mds.24012.
    PubMed     Text format     Related articles    Abstract available



  40. DE LAU LM , Verbaan D, Marinus J, Heutink P, et al
    Catechol-O-methyltransferase Val158Met and the risk of dyskinesias in Parkinson's disease.
    Mov Disord. 2011 Nov 14. doi: 10.1002/mds.23805.
    PubMed     Text format     Related articles    Abstract available



  41. JELLINGER KA
    Neuropathology of sporadic Parkinson's disease: Evaluation and changes of concepts.
    Mov Disord. 2011 Nov 11. doi: 10.1002/mds.23795.
    PubMed     Text format     Related articles    Abstract available



  42. VERNON AC , Modo M
    Do levodopa treatments modify the morphology of the parkinsonian brain?
    Mov Disord. 2011 Nov 10. doi: 10.1002/mds.24018.
    PubMed     Text format     Related articles   



  43. CERASA A , Pugliese P, Messina D, Morelli M, et al
    Prefrontal alterations in Parkinson's disease with levodopa-induced dyskinesia during fMRI motor task.
    Mov Disord. 2011 Nov 10. doi: 10.1002/mds.24017.
    PubMed     Text format     Related articles    Abstract available



  44. NISHIDA N , Murakami T, Kadoh K, Tohge R, et al
    Subthalamic nucleus deep brain stimulation restores normal rapid eye movement sleep in Parkinson's disease.
    Mov Disord. 2011;26:2418-22.
    PubMed     Text format     Related articles    Abstract available



  45. OBESO JA , Olanow W
    Deep brain stimulation for Parkinson's disease: Thinking about the long-term in the short-term.
    Mov Disord. 2011;26:2303-4.
    PubMed     Text format     Related articles   



    October 2011
  46. POLETTI M , Frosini D, Lucetti C, Del Dotto P, et al
    Iowa gambling task in de novo Parkinson's disease: A comparison between good and poor performers.
    Mov Disord. 2011 Oct 31. doi: 10.1002/mds.23982.
    PubMed     Text format     Related articles   



  47. LORENZO-BETANCOR O , Samaranch L, Ezquerra M, Tolosa E, et al
    LRRK2 haplotype-sharing analysis in Parkinson's disease reveals a novel p.S1761R mutation.
    Mov Disord. 2011 Oct 28. doi: 10.1002/mds.23968.
    PubMed     Text format     Related articles    Abstract available



  48. SCHMID SP , Schleicher ED, Cegan A, Deuschle C, et al
    Cerebrospinal fluid fatty acids in glucocerebrosidase-associated Parkinson's disease.
    Mov Disord. 2011 Oct 21. doi: 10.1002/mds.23984.
    PubMed     Text format     Related articles    Abstract available



  49. VERCRUYSSE S , Spildooren J, Heremans E, Vandenbossche J, et al
    Freezing in Parkinson's disease: A spatiotemporal motor disorder beyond gait.
    Mov Disord. 2011 Oct 21. doi: 10.1002/mds.24015.
    PubMed     Text format     Related articles    Abstract available



  50. COWIE D , Limousin P, Peters A, Hariz M, et al
    Doorway-provoked freezing of gait in Parkinson's disease.
    Mov Disord. 2011 Oct 13. doi: 10.1002/mds.23990.
    PubMed     Text format     Related articles    Abstract available



  51. TASSORELLI C , Furnari A, Buscone S, Alfonsi E, et al
    Pisa syndrome in Parkinson's disease: Clinical, electromyographic, and radiological characterization.
    Mov Disord. 2011 Oct 13. doi: 10.1002/mds.23930.
    PubMed     Text format     Related articles    Abstract available



  52. VAN DER HOORN A , Burger H, Leenders KL, de Jong BM, et al
    Handedness correlates with the dominant parkinson side: A systematic review and meta-analysis.
    Mov Disord. 2011 Oct 12. doi: 10.1002/mds.24007.
    PubMed     Text format     Related articles    Abstract available



  53. BALLANGER B , Klinger H, Eche J, Lerond J, et al
    Role of serotonergic 1A receptor dysfunction in depression associated with Parkinson's disease.
    Mov Disord. 2011 Oct 12. doi: 10.1002/mds.23895.
    PubMed     Text format     Related articles    Abstract available



  54. GUAN J , Lu Z, Zhou Q
    Reversible parkinsonism due to involvement of substantia nigra in Epstein-Barr virus encephalitis.
    Mov Disord. 2011 Oct 11. doi: 10.1002/mds.23935.
    PubMed     Text format     Related articles   



  55. KUDLICKA A , Clare L, Hindle JV
    Executive functions in Parkinson's disease: Systematic review and meta-analysis.
    Mov Disord. 2011 Oct 3. doi: 10.1002/mds.23868.
    PubMed     Text format     Related articles    Abstract available



  56. TOFT M , Dietrichs E
    Levodopa-responsive parkinsonism in probable extrapontine myelinolysis of the mesencephalon.
    Mov Disord. 2011;26:2180-1.
    PubMed     Text format     Related articles   



  57. CARPENTER MG , Bloem BR
    A new twist on turning movements in Parkinson's disease patients.
    Mov Disord. 2011;26:2151-3.
    PubMed     Text format     Related articles   



  58. SEPPI K , Weintraub D, Coelho M, Perez-Lloret S, et al
    The Movement Disorder Society Evidence-Based Medicine Review Update: Treatments for the non-motor symptoms of Parkinson's disease.
    Mov Disord. 2011;26 Suppl 3:S42-80.
    PubMed     Text format     Related articles    Abstract available



  59. FOX SH , Katzenschlager R, Lim SY, Ravina B, et al
    The Movement Disorder Society Evidence-Based Medicine Review Update: Treatments for the motor symptoms of Parkinson's disease.
    Mov Disord. 2011;26 Suppl 3:S2-S41.
    PubMed     Text format     Related articles    Abstract available



    September 2011
  60. NICOLETTI A , Nicoletti G, Arabia G, Annesi G, et al
    Reproductive factors and Parkinson's disease: A multicenter case-control study.
    Mov Disord. 2011 Sep 28. doi: 10.1002/mds.23951.
    PubMed     Text format     Related articles    Abstract available



  61. SIERRA M , Gonzalez-Aramburu I, Sanchez-Juan P, Sanchez-Quintana C, et al
    High frequency and reduced penetrance of lRRK2 g2019S mutation among Parkinson's disease patients in Cantabria (Spain).
    Mov Disord. 2011 Sep 27. doi: 10.1002/mds.23965.
    PubMed     Text format     Related articles    Abstract available



  62. WALSH RA , Lang AE
    Multiple impulse control disorders developing in Parkinson's disease after initiation of amantadine.
    Mov Disord. 2011 Sep 27. doi: 10.1002/mds.23964.
    PubMed     Text format     Related articles   



  63. HINNELL C , Hurt CS, Landau S, Brown RG, et al
    Nonmotor versus motor symptoms: How much do they matter to health status in Parkinson's disease?
    Mov Disord. 2011 Sep 27. doi: 10.1002/mds.23961.
    PubMed     Text format     Related articles    Abstract available



  64. SEKI M , Takahashi K, Koto A, Mihara B, et al
    Camptocormia in Japanese patients with Parkinson's disease: A multicenter study.
    Mov Disord. 2011 Sep 27. doi: 10.1002/mds.23955.
    PubMed     Text format     Related articles    Abstract available



  65. ARCHIBALD NK , Clarke MP, Mosimann UP, Burn DJ, et al
    Visual symptoms in Parkinson's disease and Parkinson's disease dementia.
    Mov Disord. 2011 Sep 27. doi: 10.1002/mds.23891.
    PubMed     Text format     Related articles    Abstract available



  66. TRIPOLITI E , Strong L, Hickey F, Foltynie T, et al
    Treatment of dysarthria following subthalamic nucleus deep brain stimulation for Parkinson's disease.
    Mov Disord. 2011 Sep 27. doi: 10.1002/mds.23887.
    PubMed     Text format     Related articles    Abstract available



  67. ALTMAN RD , Lang AE, Postuma RB
    Caffeine in Parkinson's disease: A pilot open-label, dose-escalation study.
    Mov Disord. 2011 Sep 27. doi: 10.1002/mds.23873.
    PubMed     Text format     Related articles    Abstract available



  68. WINWARD C , Sackley C, Meek C, Izadi H, et al
    Weekly exercise does not improve fatigue levels in Parkinson's disease.
    Mov Disord. 2011 Sep 27. doi: 10.1002/mds.23966.
    PubMed     Text format     Related articles    Abstract available



  69. HA AD , Jankovic J
    Pain in Parkinson's disease.
    Mov Disord. 2011 Sep 23. doi: 10.1002/mds.23959.
    PubMed     Text format     Related articles    Abstract available



  70. MENERET A , Mignot C, An I, Habert MO, et al
    Generalized dystonia, athetosis, and parkinsonism associated with FOXG1 mutation.
    Mov Disord. 2011 Sep 23. doi: 10.1002/mds.23956.
    PubMed     Text format     Related articles   



  71. DING H , Sarokhan AK, Roderick SS, Bakshi R, et al
    Association of SNCA with Parkinson: Replication in the Harvard NeuroDiscovery Center Biomarker Study.
    Mov Disord. 2011 Sep 23. doi: 10.1002/mds.23934.
    PubMed     Text format     Related articles    Abstract available



  72. SHINE JM , Halliday GM, Naismith SL, Lewis SJ, et al
    Visual misperceptions and hallucinations in Parkinson's disease: Dysfunction of attentional control networks?
    Mov Disord. 2011 Sep 23. doi: 10.1002/mds.23896.
    PubMed     Text format     Related articles    Abstract available



  73. ESPAY AJ , Giuffrida JP, Chen R, Payne M, et al
    Differential response of speed, amplitude, and rhythm to dopaminergic medications in Parkinson's disease.
    Mov Disord. 2011 Sep 23. doi: 10.1002/mds.23893.
    PubMed     Text format     Related articles    Abstract available



  74. HEINITZ S , Klein C, Djarmati A
    The p.S77N presenilin-associated rhomboid-like protein mutation is not a frequent cause of early-onset Parkinson's disease.
    Mov Disord. 2011 Sep 23. doi: 10.1002/mds.23889.
    PubMed     Text format     Related articles   



  75. LEE HW , Choi J, Suk K
    Increases of pentraxin 3 plasma levels in patients with Parkinson's disease.
    Mov Disord. 2011 Sep 23. doi: 10.1002/mds.23871.
    PubMed     Text format     Related articles    Abstract available



  76. KOBYLECKI C , Hill MP, Crossman AR, Ravenscroft P, et al
    Synergistic antidyskinetic effects of topiramate and amantadine in animal models of Parkinson's disease.
    Mov Disord. 2011 Sep 23. doi: 10.1002/mds.23867.
    PubMed     Text format     Related articles    Abstract available



  77. EMELYANOV A , Boukina T, Yakimovskii A, Usenko T, et al
    Glucocerebrosidase gene mutations are associated with Parkinson's disease in Russia.
    Mov Disord. 2011 Sep 13. doi: 10.1002/mds.23950.
    PubMed     Text format     Related articles   



  78. SANTANGELO G , Vitale C, Trojano L, Errico D, et al
    Neuropsychological correlates of theory of mind in patients with early Parkinson's disease.
    Mov Disord. 2011 Sep 13. doi: 10.1002/mds.23949.
    PubMed     Text format     Related articles    Abstract available



  79. GALLAGHER DA , Goetz CG, Stebbins G, Lees AJ, et al
    Validation of the MDS-UPDRS Part I for nonmotor symptoms in Parkinson's disease.
    Mov Disord. 2011 Sep 13. doi: 10.1002/mds.23939.
    PubMed     Text format     Related articles    Abstract available



  80. POSADA IJ , Benito-Leon J, Louis ED, Trincado R, et al
    Mortality from Parkinson's disease: A population-based prospective study (NEDICES).
    Mov Disord. 2011 Sep 13. doi: 10.1002/mds.23921.
    PubMed     Text format     Related articles    Abstract available



  81. SEMENOVA EV , Shadrina MI, Slominsky PA, Ivanova-Smolenskaya IA, et al
    Analysis of PARK2 gene exon rearrangements in Russian patients with sporadic Parkinson's disease.
    Mov Disord. 2011 Sep 13. doi: 10.1002/mds.23901.
    PubMed     Text format     Related articles    Abstract available



  82. STOCCHI F , Borgohain R, Onofrj M, Schapira AH, et al
    A randomized, double-blind, placebo-controlled trial of safinamide as add-on therapy in early Parkinson's disease patients.
    Mov Disord. 2011 Sep 12. doi: 10.1002/mds.23954.
    PubMed     Text format     Related articles    Abstract available



  83. YARNALL A , Rochester L, Burn DJ
    The interplay of cholinergic function, attention, and falls in Parkinson's disease.
    Mov Disord. 2011 Sep 6. doi: 10.1002/mds.23932.
    PubMed     Text format     Related articles    Abstract available



  84. DEVINE MJ , Gwinn K, Singleton A, Hardy J, et al
    Parkinson's disease and alpha-synuclein expression.
    Mov Disord. 2011 Sep 1. doi: 10.1002/mds.23948.
    PubMed     Text format     Related articles    Abstract available



  85. CHINNAPONGSE R , Gullo K, Nemeth P, Zhang Y, et al
    Safety and efficacy of botulinum toxin type B for treatment of sialorrhea in Parkinson's disease: A prospective double-blind trial.
    Mov Disord. 2011 Sep 1. doi: 10.1002/mds.23929.
    PubMed     Text format     Related articles    Abstract available



    August 2011
  86. ZIBETTI M , Merola A, Rizzi L, Ricchi V, et al
    Beyond nine years of continuous subthalamic nucleus deep brain stimulation in Parkinson's disease.
    Mov Disord. 2011 Aug 25. doi: 10.1002/mds.23903.
    PubMed     Text format     Related articles    Abstract available



  87. ZHAN W , Kang GA, Glass GA, Zhang Y, et al
    Regional alterations of brain microstructure in parkinson's disease using diffusion tensor imaging.
    Mov Disord. 2011 Aug 17. doi: 10.1002/mds.23917.
    PubMed     Text format     Related articles    Abstract available



  88. KIMURA N , Hanaki S, Masuda T, Hanaoka T, et al
    Brain perfusion differences in Parkinsonian disorders.
    Mov Disord. 2011 Aug 9. doi: 10.1002/mds.23915.
    PubMed     Text format     Related articles    Abstract available



  89. PIHLSTROM L , Toft M
    Parkinson's disease: What remains of the "missing heritability"?
    Mov Disord. 2011 Aug 2. doi: 10.1002/mds.23898.
    PubMed     Text format     Related articles   



  90. KAUTHER KM , Hoft C, Rissling I, Oertel WH, et al
    The PLA2G6 gene in early-onset Parkinson's disease.
    Mov Disord. 2011 Aug 2. doi: 10.1002/mds.23851.
    PubMed     Text format     Related articles    Abstract available



  91. SANTINI E
    Back to the origin of Parkinson's disease therapy: the use of anti-cholinergic drugs to dampen levodopa-induced dyskinesia.
    Mov Disord. 2011;26:1617.
    PubMed     Text format     Related articles   



  92. SAUNDERS-PULLMAN R , Cabassa J, San Luciano M, Stanley K, et al
    LRRK2 G2019S mutations may be increased in Puerto Ricans.
    Mov Disord. 2011;26:1772-3.
    PubMed     Text format     Related articles   



    July 2011
  93. SERRANOVA T , Jech R, Dusek P, Sieger T, et al
    Subthalamic nucleus stimulation affects incentive salience attribution in Parkinson's disease.
    Mov Disord. 2011 Jul 20. doi: 10.1002/mds.23880.
    PubMed     Text format     Related articles    Abstract available



  94. ANTONINI A , Martinez-Martin P, Chaudhuri RK, Merello M, et al
    Wearing-off scales in Parkinson's disease: Critique and recommendations.
    Mov Disord. 2011 Jul 20. doi: 10.1002/mds.23875.
    PubMed     Text format     Related articles    Abstract available



  95. BENITO-LEON J , Cubo E, Coronell C
    Impact of apathy on health-related quality of life in recently diagnosed Parkinson's disease: The ANIMO study.
    Mov Disord. 2011 Jul 20. doi: 10.1002/mds.23872.
    PubMed     Text format     Related articles    Abstract available



  96. KOKUBO Y , Morimoto S, Shindo A, Hirokawa Y, et al
    Cardiac (123) I-Meta-iodobenzylguanidine scintigraphy and lewy body pathology in a patient with amyotrophic lateral sclerosis and parkinsonism-dementia complex of Kii, Japan.
    Mov Disord. 2011 Jul 20. doi: 10.1002/mds.23850.
    PubMed     Text format     Related articles   



  97. SHANNON KM , Keshavarzian A, Mutlu E, Dodiya HB, et al
    Alpha-synuclein in colonic submucosa in early untreated Parkinson's disease.
    Mov Disord. 2011 Jul 15. doi: 10.1002/mds.23838.
    PubMed     Text format     Related articles    Abstract available



  98. MYLIUS V , Brebbermann J, Dohmann H, Engau I, et al
    Pain sensitivity and clinical progression in Parkinson's disease.
    Mov Disord. 2011 Jul 15. doi: 10.1002/mds.23825.
    PubMed     Text format     Related articles    Abstract available



  99. HAUSER RA , Ellenbogen AL, Metman LV, Hsu A, et al
    Crossover comparison of IPX066 and a standard levodopa formulation in advanced Parkinson's disease.
    Mov Disord. 2011 Jul 13. doi: 10.1002/mds.23861.
    PubMed     Text format     Related articles    Abstract available



  100. GOETZ CG , Stebbins GT, Ouyang B
    Visual plus nonvisual hallucinations in Parkinson's disease: Development and evolution over 10 years.
    Mov Disord. 2011 Jul 13. doi: 10.1002/mds.23835.
    PubMed     Text format     Related articles    Abstract available



  101. PALACIOS N , Gao X, McCullough ML, Jacobs EJ, et al
    Obesity, diabetes, and risk of Parkinson's disease.
    Mov Disord. 2011 Jul 7. doi: 10.1002/mds.23855.
    PubMed     Text format     Related articles    Abstract available



  102. SHOUSHTARIAN M , Murphy A, Iansek R
    Examination of central gait control mechanisms in Parkinson's disease using movement-related potentials.
    Mov Disord. 2011 Jul 7. doi: 10.1002/mds.23844.
    PubMed     Text format     Related articles    Abstract available



  103. STARKSTEIN S , Dragovic M, Jorge R, Brockman S, et al
    Diagnostic criteria for depression in Parkinson's disease: A study of symptom patterns using latent class analysis.
    Mov Disord. 2011 Jul 7. doi: 10.1002/mds.23836.
    PubMed     Text format     Related articles    Abstract available



  104. KLEIN C , Chuang R, Marras C, Lang AE, et al
    The curious case of phenocopies in families with genetic Parkinson's disease.
    Mov Disord. 2011 Jul 6. doi: 10.1002/mds.23853.
    PubMed     Text format     Related articles    Abstract available



  105. DE CHAZERON I , Llorca PM, Chereau-Boudet I, Blanc O, et al
    Hypersexuality and pathological gambling in Parkinson's disease: A cross-sectional case-control study.
    Mov Disord. 2011 Jul 6. doi: 10.1002/mds.23845.
    PubMed     Text format     Related articles    Abstract available



  106. MARTINEZ-MARTIN P , Jeukens-Visser M, Lyons KE, Rodriguez-Blazquez C, et al
    Health-related quality-of-life scales in Parkinson's disease: Critique and recommendations.
    Mov Disord. 2011 Jul 6. doi: 10.1002/mds.23834.
    PubMed     Text format     Related articles    Abstract available



    June 2011
  107. MONTGOMERY EB JR , Huang H, Walker HC, Guthrie BL, et al
    High-frequency deep brain stimulation of the putamen improves bradykinesia in Parkinson's disease.
    Mov Disord. 2011 Jun 28. doi: 10.1002/mds.23842.
    PubMed     Text format     Related articles    Abstract available



  108. MARUSIAK J , Jaskolska A, Budrewicz S, Koszewicz M, et al
    Increased muscle belly and tendon stiffness in patients with Parkinson's disease, as measured by myotonometry.
    Mov Disord. 2011 Jun 28. doi: 10.1002/mds.23841.
    PubMed     Text format     Related articles    Abstract available



  109. KLOSTERMANN F , Jugel C, Marzinzik F
    Jejunal levodopa infusion in long-term DBS patients with Parkinson's disease.
    Mov Disord. 2011 Jun 28. doi: 10.1002/mds.23833.
    PubMed     Text format     Related articles   



  110. GOLDWURM S , Tunesi S, Tesei S, Zini M, et al
    Kin-cohort analysis of LRRK2-G2019S penetrance in Parkinson's disease.
    Mov Disord. 2011 Jun 28. doi: 10.1002/mds.23807.
    PubMed     Text format     Related articles   



  111. FACTOR SA , Steenland NK, Higgins DS, Molho ES, et al
    Disease-related and genetic correlates of psychotic symptoms in Parkinson's disease.
    Mov Disord. 2011 Jun 28. doi: 10.1002/mds.23806.
    PubMed     Text format     Related articles    Abstract available



  112. PINTO S , Mancini L, Jahanshahi M, Thornton JS, et al
    Functional magnetic resonance imaging exploration of combined hand and speech movements in Parkinson's disease.
    Mov Disord. 2011 Jun 28. doi: 10.1002/mds.23799.
    PubMed     Text format     Related articles    Abstract available



  113. BONDON-GUITTON E , Perez-Lloret S, Bagheri H, Brefel C, et al
    Drug-induced parkinsonism: A review of 17 years' experience in a regional pharmacovigilance center in France.
    Mov Disord. 2011 Jun 14. doi: 10.1002/mds.23828.
    PubMed     Text format     Related articles    Abstract available



  114. ALLEN NE , Sherrington C, Paul SS, Canning CG, et al
    Balance and falls in Parkinson's disease: A meta-analysis of the effect of exercise and motor training.
    Mov Disord. 2011 Jun 14. doi: 10.1002/mds.23790.
    PubMed     Text format     Related articles    Abstract available



  115. BOERTIEN T , Zrinzo L, Kahan J, Jahanshahi M, et al
    Functional imaging of subthalamic nucleus deep brain stimulation in Parkinson's disease.
    Mov Disord. 2011 Jun 14. doi: 10.1002/mds.23788.
    PubMed     Text format     Related articles    Abstract available



  116. MCCLELLAND S 3RD
    A cost analysis of intraoperative microelectrode recording during subthalamic stimulation for Parkinson's disease.
    Mov Disord. 2011 Jun 14. doi: 10.1002/mds.23787.
    PubMed     Text format     Related articles    Abstract available



  117. KRISHNAN S , Sarma G, Sarma S, Kishore A, et al
    Do nonmotor symptoms in Parkinson's disease differ from normal aging?
    Mov Disord. 2011 Jun 9. doi: 10.1002/mds.23826.
    PubMed     Text format     Related articles    Abstract available



  118. LITVAN I , Aarsland D, Adler CH, Goldman JG, et al
    MDS task force on mild cognitive impairment in Parkinson's disease: Critical review of PD-MCI.
    Mov Disord. 2011 Jun 9. doi: 10.1002/mds.23823.
    PubMed     Text format     Related articles    Abstract available



  119. DJAMSHIDIAN A , Cardoso F, Grosset D, Bowden-Jones H, et al
    Pathological gambling in Parkinson's disease-a review of the literature.
    Mov Disord. 2011 Jun 9. doi: 10.1002/mds.23821.
    PubMed     Text format     Related articles    Abstract available



  120. ASSOGNA F , Cravello L, Caltagirone C, Spalletta G, et al
    Anhedonia in Parkinson's disease: A systematic review of the literature.
    Mov Disord. 2011 Jun 9. doi: 10.1002/mds.23815.
    PubMed     Text format     Related articles    Abstract available



  121. DOMELLOF ME , Elgh E, Forsgren L
    The relation between cognition and motor dysfunction in drug-naive newly diagnosed patients with Parkinson's disease.
    Mov Disord. 2011 Jun 9. doi: 10.1002/mds.23814.
    PubMed     Text format     Related articles    Abstract available



  122. ANASTASOPOULOS D , Ziavra N, Savvidou E, Bain P, et al
    Altered eye-to-foot coordination in standing parkinsonian patients during large gaze and whole-body reorientations.
    Mov Disord. 2011 Jun 9. doi: 10.1002/mds.23798.
    PubMed     Text format     Related articles    Abstract available



  123. GARBAYO E , Ansorena E, Luis Lanciego J, Jose Blanco-Prieto M, et al
    Long-term neuroprotection and neurorestoration by glial cell-derived neurotrophic factor microspheres for the treatment of parkinson's disease.
    Mov Disord. 2011 Jun 9. doi: 10.1002/mds.23793.
    PubMed     Text format     Related articles    Abstract available



  124. LATOURELLE JC , Hendricks AE, Pankratz N, Wilk JB, et al
    Genomewide linkage study of modifiers of LRRK2-related Parkinson's disease.
    Mov Disord. 2011 Jun 9. doi: 10.1002/mds.23781.
    PubMed     Text format     Related articles    Abstract available



  125. TOFT M , Lilleeng B, Ramm-Pettersen J, Skogseid IM, et al
    Long-term efficacy and mortality in Parkinson's disease patients treated with subthalamic stimulation.
    Mov Disord. 2011 Jun 8. doi: 10.1002/mds.23817.
    PubMed     Text format     Related articles    Abstract available



  126. GWINN K , Devine MJ, Jin LW, Johnson J, et al
    Clinical features, with video documentation, of the original familial lewy body Parkinsonism caused by alpha-synuclein triplication (Iowa kindred).
    Mov Disord. 2011 Jun 8. doi: 10.1002/mds.23776.
    PubMed     Text format     Related articles   



  127. DAMHOLDT MF , Borghammer P, Larsen L, Ostergaard K, et al
    Odor identification deficits identify Parkinson's disease patients with poor cognitive performance.
    Mov Disord. 2011 Jun 2. doi: 10.1002/mds.23782.
    PubMed     Text format     Related articles    Abstract available



  128. PALOMAR FJ , Diaz-Corrales F, Carrillo F, Fernandez-Del-Olmo M, et al
    Sensory perception changes induced by transcranial magnetic stimulation over the primary somatosensory cortex in Parkinson's disease.
    Mov Disord. 2011 Jun 2. doi: 10.1002/mds.23779.
    PubMed     Text format     Related articles    Abstract available



  129. GALLAGHER CL , Christian BT, Holden JE, Dejesus OT, et al
    A within-subject comparison of 6-[18F]fluoro-m-tyrosine and 6-[18F]fluoro-L-dopa in Parkinson's disease.
    Mov Disord. 2011 Jun 2. doi: 10.1002/mds.23778.
    PubMed     Text format     Related articles    Abstract available



  130. HALBIG TD , Assuras S, Creighton J, Borod JC, et al
    Differential role of dopamine in emotional attention and memory: Evidence from Parkinson's disease.
    Mov Disord. 2011 Jun 2. doi: 10.1002/mds.23728.
    PubMed     Text format     Related articles    Abstract available



  131. IVAN R , Irena R
    Pathology of vessels supplying the brain in patients with Parkinson's disease.
    Mov Disord. 2011;26:1363.
    PubMed     Text format     Related articles   



  132. DEHAY B , Bezard E
    New animal models of Parkinson's disease.
    Mov Disord. 2011;26:1198-1205.
    PubMed     Text format     Related articles    Abstract available



  133. BERG D , Godau J, Trenkwalder C, Eggert K, et al
    AFQ056 treatment of levodopa-induced dyskinesias: results of 2 randomized controlled trials.
    Mov Disord. 2011;26:1243-50.
    PubMed     Text format     Related articles    Abstract available



    May 2011
  134. HENDERSON T , Georgiou-Karistianis N, White O, Millist L, et al
    Inhibitory control during smooth pursuit in Parkinson's disease and Huntington's disease.
    Mov Disord. 2011 May 31. doi: 10.1002/mds.23757.
    PubMed     Text format     Related articles    Abstract available



  135. WANG MT , Lian PW, Yeh CB, Yen CH, et al
    Incidence, prescription patterns, and determinants of antipsychotic use in patients with Parkinson's disease.
    Mov Disord. 2011 May 31. doi: 10.1002/mds.23719.
    PubMed     Text format     Related articles    Abstract available



  136. DUJARDIN K , Dubois B, Tison F, Durif F, et al
    Reply: Brief cognitive tests in the screening of dementia in Parkinson's disease.
    Mov Disord. 2011 May 28. doi: 10.1002/mds.23802.
    PubMed     Text format     Related articles   



  137. PAGONABARRAGA J , Kulisevsky J
    Brief cognitive tests in the screening of dementia in Parkinson's disease.
    Mov Disord. 2011 May 28. doi: 10.1002/mds.23801.
    PubMed     Text format     Related articles   



  138. STAMELOU M , Kojovic M, Edwards MJ, Bhatia KP, et al
    Ability to cycle despite severe freezing of gait in atypical parkinsonism in Fahr's syndrome.
    Mov Disord. 2011 May 28. doi: 10.1002/mds.23794.
    PubMed     Text format     Related articles   



  139. XIROMERISIOU G , Kyratzi E, Dardiotis E, Bozi M, et al
    Lack of Association of the UCHL-1 gene with Parkinson's disease in a greek cohort: A haplotype-tagging approach.
    Mov Disord. 2011 May 28. doi: 10.1002/mds.23694.
    PubMed     Text format     Related articles   



  140. SHACHAR T , Bianco CL, Recchia A, Wiessner C, et al
    Lysosomal storage disorders and Parkinson's disease: Gaucher disease and beyond.
    Mov Disord. 2011 May 26. doi: 10.1002/mds.23774.
    PubMed     Text format     Related articles    Abstract available



  141. ALBANI G , El Assawy N, Cattaldo S, De Gennaro M, et al
    Electrogastrographyc activity in Parkinson's disease patients with and without motor fluctuations.
    Mov Disord. 2011 May 26. doi: 10.1002/mds.23662.
    PubMed     Text format     Related articles    Abstract available



  142. DU G , Lewis MM, Styner M, Shaffer ML, et al
    Combined R2* and Diffusion Tensor Imaging Changes in the Substantia Nigra in Parkinson's Disease.
    Mov Disord. 2011 May 26. doi: 10.1002/mds.23643.
    PubMed     Text format     Related articles    Abstract available



  143. SPAGNOLO F , Ceppi D, Cardamone R, Falautano M, et al
    Frontotemporal dementia with parkinsonism presenting as posterior cortical atrophy.
    Mov Disord. 2011 May 25. doi: 10.1002/mds.23768.
    PubMed     Text format     Related articles   



  144. MORLEY JF , Weintraub D, Mamikonyan E, Moberg PJ, et al
    Olfactory dysfunction is associated with neuropsychiatric manifestations in Parkinson's disease.
    Mov Disord. 2011 May 24. doi: 10.1002/mds.23792.
    PubMed     Text format     Related articles    Abstract available



  145. RUIZ-MARTINEZ J , Gorostidi A, Goyenechea E, Alzualde A, et al
    Olfactory deficits and cardiac (123) I-MIBG in Parkinson's disease related to the LRRK2 R1441G and G2019S mutations.
    Mov Disord. 2011 May 24. doi: 10.1002/mds.23773.
    PubMed     Text format     Related articles    Abstract available



  146. MOLLION H , Ford Dominey P, Broussolle E, Ventre-Dominey J, et al
    Subthalamic nucleus stimulation selectively improves motor and visual memory performance in Parkinson's disease.
    Mov Disord. 2011 May 24. doi: 10.1002/mds.23769.
    PubMed     Text format     Related articles    Abstract available



  147. SHANKER V , Groves M, Heiman G, Palmese C, et al
    Mood and cognition in leucine-rich repeat kinase 2 G2019S Parkinson's disease.
    Mov Disord. 2011 May 24. doi: 10.1002/mds.23746.
    PubMed     Text format     Related articles    Abstract available



  148. POLITIS M , Oertel WH, Wu K, Quinn NP, et al
    Graft-induced dyskinesias in Parkinson's disease: High striatal serotonin/dopamine transporter ratio.
    Mov Disord. 2011 May 24. doi: 10.1002/mds.23743.
    PubMed     Text format     Related articles    Abstract available



  149. KNIPE MD , Wickremaratchi MM, Wyatt-Haines E, Morris HR, et al
    Quality of life in young- compared with late-onset Parkinson's disease.
    Mov Disord. 2011 May 13. doi: 10.1002/mds.23763.
    PubMed     Text format     Related articles    Abstract available



  150. TEODORO T , Pires D, Rosa MM, Coelho M, et al
    Has "levodopa-induced neuropathy" been reported in Parkinson's disease clinical trials?
    Mov Disord. 2011 May 12. doi: 10.1002/mds.23760.
    PubMed     Text format     Related articles   



  151. MILENKOVA M , Mohammadi B, Kollewe K, Schrader C, et al
    Intertemporal choice in Parkinson's disease.
    Mov Disord. 2011 May 12. doi: 10.1002/mds.23756.
    PubMed     Text format     Related articles    Abstract available



  152. HALL DA , Berry-Kravis E, Zhang W, Tassone F, et al
    FMR1 gray-zone alleles: Association with Parkinson's disease in women?
    Mov Disord. 2011 May 12. doi: 10.1002/mds.23755.
    PubMed     Text format     Related articles    Abstract available



  153. BUCCINO G , Gatti R, Giusti MC, Negrotti A, et al
    Action observation treatment improves autonomy in daily activities in Parkinson's disease patients: Results from a pilot study.
    Mov Disord. 2011 May 5. doi: 10.1002/mds.23745.
    PubMed     Text format     Related articles   



  154. TRAON AP , Amarenco G, Duerr S, Kaufmann H, et al
    The Movement disorders task force review of dysautonomia rating scales in Parkinson's disease with regard to symptoms of orthostatic hypotension.
    Mov Disord. 2011 May 5. doi: 10.1002/mds.23742.
    PubMed     Text format     Related articles    Abstract available



  155. HALLETT M
    Bradykinesia: Why do Parkinson's patients have it and what trouble does it cause?
    Mov Disord. 2011 May 5. doi: 10.1002/mds.23730.
    PubMed     Text format     Related articles   



  156. VERBAAN D , Jeukens-Visser M, Van Laar T, van Rooden SM, et al
    SCOPA-cognition cutoff value for detection of Parkinson's disease dementia.
    Mov Disord. 2011 May 3. doi: 10.1002/mds.23750.
    PubMed     Text format     Related articles   



  157. NAKAMURA T , Hirayama M, Hara T, Hama T, et al
    Does cardiovascular autonomic dysfunction contribute to fatigue in Parkinson's disease?
    Mov Disord. 2011 May 3. doi: 10.1002/mds.23744.
    PubMed     Text format     Related articles   



  158. REMPLE MS , Bradenham CH, Kao CC, Charles PD, et al
    Subthalamic nucleus neuronal firing rate increases with Parkinson's disease progression.
    Mov Disord. 2011 May 3. doi: 10.1002/mds.23708.
    PubMed     Text format     Related articles   



  159. CAVINESS JN , Lue LF, Beach TG, Hentz JG, et al
    Parkinson's disease, cortical dysfunction, and alpha-synuclein.
    Mov Disord. 2011 May 3. doi: 10.1002/mds.23697.
    PubMed     Text format     Related articles   



  160. VAN LIESHOUT PH , Steele CM, Lang AE
    Tongue control for swallowing in Parkinson's disease: Effects of age, rate, and stimulus consistency.
    Mov Disord. 2011 May 3. doi: 10.1002/mds.23690.
    PubMed     Text format     Related articles   



  161. CHIASSERINI D , Tozzi A, de Iure A, Tantucci M, et al
    Mortalin inhibition in experimental Parkinson's disease.
    Mov Disord. 2011 May 3. doi: 10.1002/mds.23647.
    PubMed     Text format     Related articles   



  162. SAMPAIO C , Bronzova J, Hauser RA, Lang AE, et al
    Pardoprunox in early Parkinson's disease: Results from 2 large, randomized double-blind trials.
    Mov Disord. 2011 May 3. doi: 10.1002/mds.23590.
    PubMed     Text format     Related articles   



  163. WENNING GK , Litvan I, Tolosa E
    Milestones in atypical and secondary Parkinsonisms.
    Mov Disord. 2011;26:1083-95.
    PubMed     Text format     Related articles    Abstract available



  164. RASCOL O , Lozano A, Stern M, Poewe W, et al
    Milestones in Parkinson's disease therapeutics.
    Mov Disord. 2011;26:1072-82.
    PubMed     Text format     Related articles    Abstract available



  165. OLANOW CW , McNaught K
    Parkinson's disease, proteins, and prions: Milestones.
    Mov Disord. 2011;26:1056-71.
    PubMed     Text format     Related articles    Abstract available



  166. SCHAPIRA AH , Jenner P
    Etiology and pathogenesis of Parkinson's disease.
    Mov Disord. 2011;26:1049-55.
    PubMed     Text format     Related articles    Abstract available



  167. WICHMANN T , Delong MR, Guridi J, Obeso JA, et al
    Milestones in research on the pathophysiology of Parkinson's disease.
    Mov Disord. 2011;26:1032-41.
    PubMed     Text format     Related articles    Abstract available



  168. WEINTRAUB D , Burn DJ
    Parkinson's disease: The quintessential neuropsychiatric disorder.
    Mov Disord. 2011;26:1022-31.
    PubMed     Text format     Related articles    Abstract available



  169. HALLIDAY G , Lees A, Stern M
    Milestones in Parkinson's disease-Clinical and pathologic features.
    Mov Disord. 2011;26:1015-21.
    PubMed     Text format     Related articles    Abstract available



  170. BEZARD E , Przedborski S
    A tale on animal models of Parkinson's Disease.
    Mov Disord. 2011;26:993-1002.
    PubMed     Text format     Related articles    Abstract available



  171. GASSER T , Hardy J, Mizuno Y
    Milestones in PD genetics.
    Mov Disord. 2011;26:1042-8.
    PubMed     Text format     Related articles    Abstract available



    April 2011
  172. SCHWARZSCHILD MA , Marek K, Eberly S, Oakes D, et al
    Serum urate and probability of dopaminergic deficit in early "Parkinson's disease"
    Mov Disord. 2011 Apr 29. doi: 10.1002/mds.23741.
    PubMed     Text format     Related articles   



  173. HELDMAN DA , Giuffrida JP, Chen R, Payne M, et al
    The modified bradykinesia rating scale for Parkinson's disease: Reliability and comparison with kinematic measures.
    Mov Disord. 2011 Apr 29. doi: 10.1002/mds.23740.
    PubMed     Text format     Related articles   



  174. YUE Z , Lachenmayer ML
    Genetic LRRK2 models of Parkinson's disease: Dissecting the pathogenic pathway and exploring clinical applications.
    Mov Disord. 2011 Apr 29. doi: 10.1002/mds.23737.
    PubMed     Text format     Related articles   



  175. CRISCUOLO C , De Rosa A, Guacci A, Simons EJ, et al
    The LRRK2 R1441C mutation is more frequent than G2019S in Parkinson's disease patients from Southern Italy.
    Mov Disord. 2011 Apr 29. doi: 10.1002/mds.23735.
    PubMed     Text format     Related articles   



  176. KAPOGIANNIS D , Mooshagian E, Campion P, Grafman J, et al
    Reward processing abnormalities in Parkinson's disease.
    Mov Disord. 2011 Apr 29. doi: 10.1002/mds.23701.
    PubMed     Text format     Related articles   



  177. WONG KK , Alty JE, Goy AG, Raghav S, et al
    A randomized, double-blind, placebo-controlled trial of levetiracetam for dyskinesia in Parkinson's disease.
    Mov Disord. 2011 Apr 29. doi: 10.1002/mds.23687.
    PubMed     Text format     Related articles   



  178. POSTUMA RB , Montplaisir J, Lanfranchi P, Blais H, et al
    Cardiac autonomic denervation in Parkinson's disease is linked to REM sleep behavior disorder.
    Mov Disord. 2011 Apr 29. doi: 10.1002/mds.23677.
    PubMed     Text format     Related articles   



  179. VOSSIUS C , Larsen JP, Janvin C, Aarsland D, et al
    The economic impact of cognitive impairment in Parkinson's disease.
    Mov Disord. 2011 Apr 29. doi: 10.1002/mds.23661.
    PubMed     Text format     Related articles   



  180. SHILL HA , Obradov S, Katsnelson Y, Pizinger R, et al
    A randomized, double-blind trial of transcranial electrostimulation in early Parkinson's disease.
    Mov Disord. 2011 Apr 29. doi: 10.1002/mds.23591.
    PubMed     Text format     Related articles   



  181. SHORE DM , Rafal R, Parkinson JA
    Appetitive motivational deficits in individuals with Parkinson's Disease.
    Mov Disord. 2011 Apr 25. doi: 10.1002/mds.23736.
    PubMed     Text format     Related articles   



  182. MUTHURAMAN M , Hossen A, Heute U, Deuschl G, et al
    A new diagnostic test to distinguish tremulous Parkinson's disease from advanced essential tremor.
    Mov Disord. 2011 Apr 25. doi: 10.1002/mds.23672.
    PubMed     Text format     Related articles   



  183. SCHROETELER FE , Fietzek UM, Ziegler K, Ceballos-Baumann AO, et al
    Upright posture in parkinsonian camptocormia using a high-frame walker with forearm support.
    Mov Disord. 2011 Apr 25. doi: 10.1002/mds.23585.
    PubMed     Text format     Related articles   



  184. WANSCHITZ JV , Sawires M, Seppi K, Boesch S, et al
    Axial myopathy in parkinsonism.
    Mov Disord. 2011 Apr 25. doi: 10.1002/mds.23492.
    PubMed     Text format     Related articles   



  185. GOLDMAN JG , Marr D, Zhou L, Ouyang B, et al
    Racial differences may influence the role of cholecystokinin polymorphisms in Parkinson's disease hallucinations.
    Mov Disord. 2011 Apr 19. doi: 10.1002/mds.23655.
    PubMed     Text format     Related articles   



  186. JAIN S , Siegle GJ, Gu C, Moore CG, et al
    Pupillary unrest correlates with arousal symptoms and motor signs in Parkinson disease.
    Mov Disord. 2011 Apr 19. doi: 10.1002/mds.23628.
    PubMed     Text format     Related articles    Abstract available



  187. HANAGASI HA , Gurvit H, Unsalan P, Horozoglu H, et al
    The effects of rasagiline on cognitive deficits in Parkinson's disease patients without dementia: A randomized, double-blind, placebo-controlled, multicenter study.
    Mov Disord. 2011 Apr 15. doi: 10.1002/mds.23738.
    PubMed     Text format     Related articles    Abstract available



  188. RUZICKA E , Zarubova K, Nutt JG, Bloem BR, et al
    "Silly Walks" in Parkinson's disease: Unusual presentation of dopaminergic-induced dyskinesias.
    Mov Disord. 2011 Apr 14. doi: 10.1002/mds.23667.
    PubMed     Text format     Related articles   



  189. GIERTHMUHLEN J , Wasner G
    Reply: The influence of deep brain stimulation and levodopa on pain perception in Parkinson's disease-implications for further scientific and clinical work.
    Mov Disord. 2011 Apr 14. doi: 10.1002/mds.23568.
    PubMed     Text format     Related articles   



  190. HA AD , Jankovic J
    Parkinsonism and dystonia associated with adalimumab.
    Mov Disord. 2011 Apr 14. doi: 10.1002/mds.23548.
    PubMed     Text format     Related articles   



  191. CLARKE CE , Patel S, Ives N, Rick C, et al
    Should treatment for Parkinson's disease start immediately on diagnosis or delayed until functional disability develops?
    Mov Disord. 2011 Apr 14. doi: 10.1002/mds.23519.
    PubMed     Text format     Related articles    Abstract available



  192. ESPAY AJ , Vaughan JE, Marras C, Fowler R, et al
    Reply: Early versus delayed bilateral subthalamic deep brain stimulation for Parkinson's disease: Need for long-term clinical trials.
    Mov Disord. 2011 Apr 13. doi: 10.1002/mds.23630.
    PubMed     Text format     Related articles   



  193. SCHWARZ ST , Rittman T, Gontu V, Morgan PS, et al
    T1-Weighted MRI shows stage-dependent substantia nigra signal loss in Parkinson's disease.
    Mov Disord. 2011 Apr 12. doi: 10.1002/mds.23722.
    PubMed     Text format     Related articles    Abstract available



  194. KALF JG , Munneke M, van den Engel-Hoek L, de Swart BJ, et al
    Pathophysiology of diurnal drooling in Parkinson's disease.
    Mov Disord. 2011 Apr 11. doi: 10.1002/mds.23720.
    PubMed     Text format     Related articles    Abstract available



  195. RUSZ J , Cmejla R, Ruzickova H, Klempir J, et al
    Acoustic assessment of voice and speech disorders in Parkinson's disease through quick vocal test.
    Mov Disord. 2011 Apr 11. doi: 10.1002/mds.23680.
    PubMed     Text format     Related articles   



  196. LANG AE
    A critical appraisal of the premotor symptoms of Parkinson's disease: Potential usefulness in early diagnosis and design of neuroprotective trials.
    Mov Disord. 2011 Apr 11. doi: 10.1002/mds.23609.
    PubMed     Text format     Related articles    Abstract available



  197. SROVNALOVA H , Marecek R, Rektorova I
    The role of the inferior frontal gyri in cognitive processing of patients with Parkinson's disease: A pilot rTMS study.
    Mov Disord. 2011 Apr 7. doi: 10.1002/mds.23663.
    PubMed     Text format     Related articles    Abstract available



  198. AGOSTA F , Longoni G, Kostic VS, Stojkovic T, et al
    Reply: MRI measurements of brain stem structures in patients with Richardson's syndrome, progressive supranuclear palsy-parkinsonism, and Parkinson's disease.
    Mov Disord. 2011 Apr 5. doi: 10.1002/mds.23702.
    PubMed     Text format     Related articles   



  199. ARABIA G , Quattrone A
    MRI measurements of brainstem structures in patients with Richardson's syndrome, progressive supranuclear palsy-parkinsonism, and Parkinson's disease.
    Mov Disord. 2011 Apr 5. doi: 10.1002/mds.23703.
    PubMed     Text format     Related articles   



  200. GUO Y , Le WD, Jankovic J, Yang HR, et al
    Systematic genetic analysis of the PITX3 gene in patients with Parkinson disease.
    Mov Disord. 2011 Apr 5. doi: 10.1002/mds.23693.
    PubMed     Text format     Related articles    Abstract available



  201. PARNETTI L , Chiasserini D, Bellomo G, Giannandrea D, et al
    Cerebrospinal fluid Tau/alpha-synuclein ratio in Parkinson's disease and degenerative dementias.
    Mov Disord. 2011 Apr 5. doi: 10.1002/mds.23670.
    PubMed     Text format     Related articles    Abstract available



  202. NAISMITH SL , Terpening Z, Shine JM, Lewis SJ, et al
    Neuropsychological functioning in Parkinson's disease: Differential relationships with self-reported sleep-wake disturbances.
    Mov Disord. 2011 Apr 5. doi: 10.1002/mds.23640.
    PubMed     Text format     Related articles    Abstract available



  203. FASANO A , Daniele A, Albanese A
    Early versus delayed bilateral subthalamic deep brain stimulation for Parkinson's disease: Need for long-term clinical trials.
    Mov Disord. 2011 Apr 5. doi: 10.1002/mds.23633.
    PubMed     Text format     Related articles   



  204. CHUNG SJ , Armasu SM, Biernacka JM, Lesnick TG, et al
    Variants in estrogen-related genes and risk of Parkinson's disease.
    Mov Disord. 2011 Apr 5. doi: 10.1002/mds.23604.
    PubMed     Text format     Related articles    Abstract available



  205. RIBNER A , Altarescu G, Zimran A, Elstein D, et al
    Osteopontin polymorphic susceptibility factor for Parkinson's disease among patients with Gaucher disease.
    Mov Disord. 2011 Apr 5. doi: 10.1002/mds.23595.
    PubMed     Text format     Related articles    Abstract available



  206. MEROLA A , Zibetti M, Angrisano S, Rizzi L, et al
    Comparison of subthalamic nucleus deep brain stimulation and Duodopa in the treatment of advanced Parkinson's disease.
    Mov Disord. 2011 Apr 5. doi: 10.1002/mds.23524.
    PubMed     Text format     Related articles    Abstract available



  207. STOCCHI F , Giorgi L, Hunter B, Schapira AH, et al
    PREPARED: Comparison of prolonged and immediate release ropinirole in advanced Parkinson's disease.
    Mov Disord. 2011 Apr 5. doi: 10.1002/mds.23498.
    PubMed     Text format     Related articles    Abstract available



  208. SANTANGELO G , Vitale C, Trojano L, Angelo A, et al
    Differential neuropsychological profiles in parkinsonian patients with or without vascular lesions.
    Mov Disord. 2011 Apr 5. doi: 10.1002/mds.23451.
    PubMed     Text format     Related articles   



  209. VITALE C , Marcelli V, Furia T, Santangelo G, et al
    Vestibular impairment and adaptive postural imbalance in parkinsonian patients with lateral trunk flexion.
    Mov Disord. 2011 Apr 4. doi: 10.1002/mds.23657.
    PubMed     Text format     Related articles    Abstract available



  210. KOPRICH JB , Fox SH, Johnston TH, Goodman A, et al
    The selective mu-opioid receptor antagonist adl5510 reduces levodopa-induced dyskinesia without affecting antiparkinsonian action in mptp-lesioned macaque model of Parkinson's disease.
    Mov Disord. 2011 Apr 4. doi: 10.1002/mds.23631.
    PubMed     Text format     Related articles    Abstract available



  211. GABRIELLI M , Bonazzi P, Scarpellini E, Bendia E, et al
    Prevalence of small intestinal bacterial overgrowth in Parkinson's disease.
    Mov Disord. 2011;26:889-92.
    PubMed     Text format     Related articles   



  212. HATANO T
    A novel protein degradation system in young-onset Parkinson's disease: mitophagy is a therapeutic target as a quality control for damaged mitochondria.
    Mov Disord. 2011;26:773.
    PubMed     Text format     Related articles   



  213. KHOO TK
    Parkin inactivation via PARIS (ZNF746) may lead to neurodegeneration in Parkinson's disease.
    Mov Disord. 2011;26:772.
    PubMed     Text format     Related articles   



  214. RASMUSSEN VG , Ostergaard K, Dupont E, Poulsen SH, et al
    The risk of valvular regurgitation in patients with Parkinson's disease treated with dopamine receptor agonists.
    Mov Disord. 2011;26:801-6.
    PubMed     Text format     Related articles    Abstract available



  215. TAN LC , Ng KK, Au WL, Lee RK, et al
    Bromocriptine use and myocardial function.
    Mov Disord. 2011;26:923-4.
    PubMed     Text format     Related articles   



  216. CERASA A , Messina D, Pugliese P, Morelli M, et al
    Increased prefrontal volume in PD with levodopa-induced dyskinesias: a voxel-based morphometry study.
    Mov Disord. 2011;26:807-12.
    PubMed     Text format     Related articles    Abstract available



  217. BRUGGEMANN N , Hagenah J, Stanley K, Klein C, et al
    Substantia nigra hyperechogenicity with LRRK2 G2019S mutations.
    Mov Disord. 2011;26:885-8.
    PubMed     Text format     Related articles    Abstract available



    March 2011
  218. MATSUMOTO H , Terao Y, Furubayashi T, Yugeta A, et al
    Small saccades restrict visual scanning area in Parkinson's disease.
    Mov Disord. 2011 Mar 29. doi: 10.1002/mds.23683.
    PubMed     Text format     Related articles    Abstract available



  219. LIM SY , Farrell MJ, Evans AH
    Parkinson's disease and pain-nondopaminergic mechanisms are likely to be important too.
    Mov Disord. 2011 Mar 29. doi: 10.1002/mds.22959.
    PubMed     Text format     Related articles   



  220. LING H , Braschinsky M, Taba P, Luus SM, et al
    Decades of delayed diagnosis in 4 levodopa-responsive young-onset monogenetic parkinsonism patients.
    Mov Disord. 2011 Mar 29. doi: 10.1002/mds.23563.
    PubMed     Text format     Related articles    Abstract available



  221. KADOWAKI T , Hashimoto K, Suzuki K, Watanabe Y, et al
    Case report: Recurrent parkinsonism-hyperpyrexia syndrome following discontinuation of subthalamic deep brain stimulation.
    Mov Disord. 2011 Mar 29. doi: 10.1002/mds.23596.
    PubMed     Text format     Related articles   



  222. GALLAGHER CL , Oakes TR, Johnson SC, Chung MK, et al
    Rate of 6-[18F]fluorodopa uptake decline in striatal subregions in Parkinson's disease.
    Mov Disord. 2011 Mar 29. doi: 10.1002/mds.23503.
    PubMed     Text format     Related articles    Abstract available



  223. CAMICIOLI R , Sabino J, Gee M, Bouchard T, et al
    Ventricular dilatation and brain atrophy in patients with Parkinson's disease with incipient dementia.
    Mov Disord. 2011 Mar 25. doi: 10.1002/mds.23700.
    PubMed     Text format     Related articles    Abstract available



  224. REIFF J , Schmidt N, Riebe B, Breternitz R, et al
    Subthreshold Depression in Parkinson's Disease.
    Mov Disord. 2011 Mar 25. doi: 10.1002/mds.23699.
    PubMed     Text format     Related articles    Abstract available



  225. PARIS AP , Saleta HG, de la Cruz Crespo Maraver M, Silvestre E, et al
    Blind randomized controlled study of the efficacy of cognitive training in Parkinson's disease.
    Mov Disord. 2011 Mar 25. doi: 10.1002/mds.23688.
    PubMed     Text format     Related articles    Abstract available



  226. MIAN OS , Schneider SA, Schwingenschuh P, Bhatia KP, et al
    Gait in SWEDDs patients: Comparison with Parkinson's disease patients and healthy controls.
    Mov Disord. 2011 Mar 25. doi: 10.1002/mds.23684.
    PubMed     Text format     Related articles    Abstract available



  227. HAUSER RA , Auinger P
    Determination of minimal clinically important change in early and advanced Parkinson's disease.
    Mov Disord. 2011 Mar 24. doi: 10.1002/mds.23638.
    PubMed     Text format     Related articles    Abstract available



  228. ESPAY AJ , Vaughan JE, Shukla R, Gartner M, et al
    Botulinum toxin type A for Levodopa-induced cervical dyskinesias in Parkinson's disease: Unfavorable risk-benefit ratio.
    Mov Disord. 2011 Mar 22. doi: 10.1002/mds.23522.
    PubMed     Text format     Related articles   



  229. BRONNICK K , Emre M, Tekin S, Haugen SB, et al
    Cognitive correlates of visual hallucinations in dementia associated with Parkinson's disease.
    Mov Disord. 2011 Mar 21. doi: 10.1002/mds.23525.
    PubMed     Text format     Related articles    Abstract available



  230. MATA IF , Yearout D, Alvarez V, Coto E, et al
    Replication of MAPT and SNCA, but not PARK16-18, as susceptibility genes for parkinson's disease.
    Mov Disord. 2011 Mar 21. doi: 10.1002/mds.23642.
    PubMed     Text format     Related articles    Abstract available



  231. CHOUZA M , Arias P, Vinas S, Cudeiro J, et al
    Acute effects of whole-body vibration at 3, 6, and 9 hz on balance and gait in patients with Parkinson's disease.
    Mov Disord. 2011 Mar 21. doi: 10.1002/mds.23582.
    PubMed     Text format     Related articles   



  232. FLETCHER P , Leake A, Marion MH
    Patients with Parkinson's disease dementia stay in the hospital twice as long as those without dementia.
    Mov Disord. 2011 Mar 21. doi: 10.1002/mds.23573.
    PubMed     Text format     Related articles   



  233. INFANTE J , Sierra M, Sanchez-Juan P, Garcia-Gorostiaga I, et al
    Interaction between heme oxygenase-1 genotypes and exposure to pesticides in Parkinson's disease.
    Mov Disord. 2011 Mar 21. doi: 10.1002/mds.23527.
    PubMed     Text format     Related articles   



  234. SPIELBERGER S , Wolf E, Kress M, Seppi K, et al
    The influence of deep brain stimulation on pain perception in Parkinson's disease.
    Mov Disord. 2011 Mar 13. doi: 10.1002/mds.23570.
    PubMed     Text format     Related articles   



  235. FINSTERER J
    Parkinson's syndrome and Parkinson's disease in mitochondrial disorders.
    Mov Disord. 2011 Mar 7. doi: 10.1002/mds.23651.
    PubMed     Text format     Related articles    Abstract available



  236. STAMELOU M , Christ H, Reuss A, Oertel W, et al
    Hypodipsia discriminates progressive supranuclear palsy from other parkinsonian syndromes.
    Mov Disord. 2011 Mar 7. doi: 10.1002/mds.23587.
    PubMed     Text format     Related articles    Abstract available



  237. LEENTJENS AF , Dujardin K, Marsh L, Richard IH, et al
    Anxiety rating scales in Parkinson's disease: A validation study of the Hamilton anxiety rating scale, the Beck anxiety inventory, and the hospital anxiety and depression scale.
    Mov Disord. 2011 Mar 7. doi: 10.1002/mds.23184.
    PubMed     Text format     Related articles    Abstract available



  238. GUIDUBALDI A , Piano C, Santorelli FM, Silvestri G, et al
    Novel mutations in SPG11 cause hereditary spastic paraplegia associated with early-onset levodopa-responsive Parkinsonism.
    Mov Disord. 2011 Mar 4. doi: 10.1002/mds.23552.
    PubMed     Text format     Related articles    Abstract available



  239. ISHIOKA T , Hirayama K, Hosokai Y, Takeda A, et al
    Illusory misidentifications and cortical hypometabolism in Parkinson's disease.
    Mov Disord. 2011 Mar 2. doi: 10.1002/mds.23576.
    PubMed     Text format     Related articles    Abstract available



  240. VITALE C , Santangelo G, Trojano L, Verde F, et al
    Comparative neuropsychological profile of pathological gambling, hypersexuality, and compulsive eating in Parkinson's disease.
    Mov Disord. 2011 Mar 2. doi: 10.1002/mds.23567.
    PubMed     Text format     Related articles    Abstract available



  241. HOLFORD NH , Nutt JG
    Interpreting the results of Parkinson's disease clinical trials: Time for a change.
    Mov Disord. 2011 Mar 2. doi: 10.1002/mds.23555.
    PubMed     Text format     Related articles    Abstract available



  242. STOWE R , Ives N, Clarke CE, Handley K, et al
    Meta-analysis of the comparative efficacy and safety of adjuvant treatment to levodopa in later Parkinson's disease.
    Mov Disord. 2011 Mar 2. doi: 10.1002/mds.23517.
    PubMed     Text format     Related articles    Abstract available



  243. GAENSLEN A , Swid I, Liepelt-Scarfone I, Godau J, et al
    The patients' perception of prodromal symptoms before the initial diagnosis of Parkinson's disease.
    Mov Disord. 2011 Mar 2. doi: 10.1002/mds.23499.
    PubMed     Text format     Related articles    Abstract available



  244. SONG SK , Lee JE, Park HJ, Sohn YH, et al
    The pattern of cortical atrophy in patients with Parkinson's disease according to cognitive status.
    Mov Disord. 2011 Mar 2. doi: 10.1002/mds.23477.
    PubMed     Text format     Related articles    Abstract available



  245. NAZIR T , Thomson AM
    Domestic violence and mistreatment in patients with parkinsonism: Case reports, mechanisms, and discussion.
    Mov Disord. 2011;26:757-8.
    PubMed     Text format     Related articles   



  246. SKODDA S , Flasskamp A, Schlegel U
    Instability of syllable repetition in Parkinson's disease-Influence of levodopa and deep brain stimulation.
    Mov Disord. 2011;26:728-30.
    PubMed     Text format     Related articles    Abstract available



  247. LORENZO-BETANCOR O , Samaranch L, Garcia-Martin E, Cervantes S, et al
    LINGO1 gene analysis in Parkinson's disease phenotypes.
    Mov Disord. 2011;26:722-727.
    PubMed     Text format     Related articles    Abstract available



  248. CHO ZH , Oh SH, Kim JM, Park SY, et al
    Direct visualization of Parkinson's disease by in vivo human brain imaging using 7.0T magnetic resonance imaging.
    Mov Disord. 2011;26:713-8.
    PubMed     Text format     Related articles    Abstract available



  249. MOREAU C , Pennel-Ployart O, Pinto S, Plachez A, et al
    Modulation of dysarthropneumophonia by low-frequency STN DBS in advanced Parkinson's disease.
    Mov Disord. 2011;26:659-63.
    PubMed     Text format     Related articles    Abstract available



  250. WEINTRAUB D , Morgan JC
    Both the body and brain benefit from exercise: Potential win-win for Parkinson's disease patients.
    Mov Disord. 2011;26:607.
    PubMed     Text format     Related articles   



  251. TOFT M
    International consortium identifies new genetic risk factors for Parkinson's disease.
    Mov Disord. 2011;26:606.
    PubMed     Text format     Related articles   



  252. SPENCER AH , Rickards H, Fasano A, Cavanna AE, et al
    The prevalence and clinical characteristics of punding in Parkinson's disease.
    Mov Disord. 2011;26:578-86.
    PubMed     Text format     Related articles    Abstract available



  253. HASSIN-BAER S , Hattori N, Cohen OS, Massarwa M, et al
    Phenotype of the 202 adenine deletion in the parkin gene: 40 years of follow-up.
    Mov Disord. 2011;26:719-22.
    PubMed     Text format     Related articles    Abstract available



  254. FERNANDES C , Reddy P, Kessel B
    Rasagiline-induced serotonin syndrome.
    Mov Disord. 2011;26:766-7.
    PubMed     Text format     Related articles   



    February 2011
  255. SCHICKS J , Synofzik M, Petursson H, Huttenlocher J, et al
    Atypical juvenile parkinsonism in a consanguineous SPG15 family.
    Mov Disord. 2011;26:565-6.
    PubMed     Text format     Related articles   



  256. OGAKI K , Motoi Y, Li Y, Tomiyama H, et al
    Visual grasping in frontotemporal dementia and parkinsonism linked to chromosome 17 (microtubule-associated with protein tau): A comparison of N-Isopropyl-p-[(123) I]-iodoamphetamine brain perfusion single photon emission computed tomography analysis
    Mov Disord. 2011;26:562-3.
    PubMed     Text format     Related articles   



  257. MULLER T , Muhlack S
    Cysteinyl-glycine reduction as marker for levodopa-induced oxidative stress in Parkinson's disease patients.
    Mov Disord. 2011;26:543-6.
    PubMed     Text format     Related articles    Abstract available



  258. PERROTTA A , Sandrini G, Serrao M, Buscone S, et al
    Facilitated temporal summation of pain at spinal level in Parkinson's disease.
    Mov Disord. 2011;26:442-8.
    PubMed     Text format     Related articles    Abstract available



  259. TINAZ S , Courtney MG, Stern CE
    Focal cortical and subcortical atrophy in early Parkinson's disease.
    Mov Disord. 2011;26:436-41.
    PubMed     Text format     Related articles    Abstract available



  260. ROCHESTER L , Baker K, Nieuwboer A, Burn D, et al
    Targeting dopa-sensitive and dopa-resistant gait dysfunction in Parkinson's disease: Selective responses to internal and external cues.
    Mov Disord. 2011;26:430-5.
    PubMed     Text format     Related articles    Abstract available



  261. FABBRINI G , Merello M, Evans AH, Lees AJ, et al
    Progressive parkinsonism, oculomotor abnormalities and autonomic dysfunction: Clinicopathological case.
    Mov Disord. 2011;26:424-9.
    PubMed     Text format     Related articles    Abstract available



  262. FEKETE R , Jankovic J
    Revisiting the relationship between essential tremor and Parkinson's disease.
    Mov Disord. 2011;26:391-8.
    PubMed     Text format     Related articles   



  263. PONCE FA , Lozano AM
    The most cited works in Parkinson's disease.
    Mov Disord. 2011;26:380-90.
    PubMed     Text format     Related articles    Abstract available



  264. SNIJDERS AH , Toni I, Ruzicka E, Bloem BR, et al
    Bicycling breaks the ice for freezers of gait.
    Mov Disord. 2011;26:367-71.
    PubMed     Text format     Related articles    Abstract available



  265. MENANT JC , Latt MD, Menz HB, Fung VS, et al
    Postural sway approaches center of mass stability limits in Parkinson's disease.
    Mov Disord. 2011 Feb 10. doi: 10.1002/mds.23547.
    PubMed     Text format     Related articles    Abstract available



  266. LEENTJENS AF , Dujardin K, Marsh L, Martinez-Martin P, et al
    Symptomatology and markers of anxiety disorders in Parkinson's disease: A cross-sectional study.
    Mov Disord. 2011 Feb 10. doi: 10.1002/mds.23528.
    PubMed     Text format     Related articles    Abstract available



  267. ANTONINI A , Siri C, Santangelo G, Cilia R, et al
    Impulsivity and compulsivity in drug-naive patients with Parkinson's disease.
    Mov Disord. 2011 Feb 10. doi: 10.1002/mds.23501.
    PubMed     Text format     Related articles    Abstract available



  268. TRENKWALDER C , Kohnen R, Hogl B, Metta V, et al
    Parkinson's disease sleep scale-validation of the revised version PDSS-2.
    Mov Disord. 2011 Feb 10. doi: 10.1002/mds.23476.
    PubMed     Text format     Related articles    Abstract available



  269. POST B , Muslimovic D, van Geloven N, Speelman JD, et al
    Progression and prognostic factors of motor impairment, disability and quality of life in newly diagnosed Parkinson's disease.
    Mov Disord. 2011 Feb 10. doi: 10.1002/mds.23467.
    PubMed     Text format     Related articles    Abstract available



  270. NISHIBAYASHI H , Ogura M, Kakishita K, Tanaka S, et al
    Cortically evoked responses of human pallidal neurons recorded during stereotactic neurosurgery.
    Mov Disord. 2011 Feb 10. doi: 10.1002/mds.23502.
    PubMed     Text format     Related articles    Abstract available



  271. DALRYMPLE-ALFORD JC , Livingston L, Macaskill MR, Graham C, et al
    Characterizing mild cognitive impairment in Parkinson's disease.
    Mov Disord. 2011 Feb 1. doi: 10.1002/mds.23592.
    PubMed     Text format     Related articles    Abstract available



  272. MARRAS C , McDermott MP, Marek K, Rochon P, et al
    Predictors of time to requiring dopaminergic treatment in 2 Parkinson's disease cohorts.
    Mov Disord. 2011 Feb 1. doi: 10.1002/mds.23581.
    PubMed     Text format     Related articles    Abstract available



  273. MORELLI M , Arabia G, Salsone M, Novellino F, et al
    Accuracy of magnetic resonance parkinsonism index for differentiation of progressive supranuclear palsy from probable or possible Parkinson disease.
    Mov Disord. 2011 Feb 1. doi: 10.1002/mds.23529.
    PubMed     Text format     Related articles    Abstract available



  274. HUEBL J , Schoenecker T, Siegert S, Brucke C, et al
    Modulation of subthalamic alpha activity to emotional stimuli correlates with depressive symptoms in Parkinson's disease1.
    Mov Disord. 2011 Feb 1. doi: 10.1002/mds.23515.
    PubMed     Text format     Related articles    Abstract available



  275. KISHI M , Sakakibara R, Terada H, Ogawa E, et al
    Does levodopa affect metaiodobenzylguanidine myocardial accumulation in Parkinson's disease?
    Mov Disord. 2011 Feb 1. doi: 10.1002/mds.23464.
    PubMed     Text format     Related articles   



  276. BENINCASA D , Pellicano C, Fanciulli A, Pontieri FE, et al
    Bupropion abates dopamine agonist-mediated compulsive behaviors in Parkinson's disease.
    Mov Disord. 2011;26:355-7.
    PubMed     Text format     Related articles   



  277. DALAKER TO , Zivadinov R, Ramasamy DP, Beyer MK, et al
    Ventricular enlargement and mild cognitive impairment in early Parkinson's disease.
    Mov Disord. 2011;26:297-301.
    PubMed     Text format     Related articles    Abstract available



  278. CHUNG SJ , Armasu SM, Biernacka JM, Lesnick TG, et al
    Common variants in PARK loci and related genes and Parkinson's disease.
    Mov Disord. 2011;26:280-8.
    PubMed     Text format     Related articles    Abstract available



  279. MOISAN F , Spinosi J, Dupupet JL, Delabre L, et al
    The relation between type of farming and prevalence of Parkinson's disease among agricultural workers in five french districts.
    Mov Disord. 2011;26:271-9.
    PubMed     Text format     Related articles    Abstract available



  280. STATHIS P , Konitsiotis S, Tagaris G, Peterson D, et al
    Levetiracetam for the management of levodopa-induced dyskinesias in Parkinson's disease.
    Mov Disord. 2011;26:264-270.
    PubMed     Text format     Related articles    Abstract available



  281. SCHOFIELD EC , Hodges JR, Macdonald V, Cordato NJ, et al
    Cortical atrophy differentiates Richardson's syndrome from the parkinsonian form of progressive supranuclear palsy.
    Mov Disord. 2011;26:256-63.
    PubMed     Text format     Related articles    Abstract available



  282. LONGONI G , Agosta F, Kostic VS, Stojkovic T, et al
    MRI measurements of brainstem structures in patients with Richardson's syndrome, progressive supranuclear palsy-parkinsonism, and Parkinson's disease.
    Mov Disord. 2011;26:247-55.
    PubMed     Text format     Related articles    Abstract available



  283. EBERSBACH G , Gunkel M
    Posturography reflects clinical imbalance in Parkinson's disease.
    Mov Disord. 2011;26:241-6.
    PubMed     Text format     Related articles    Abstract available



  284. PISANI V , Madeo G, Tassone A, Sciamanna G, et al
    Homeostatic changes of the endocannabinoid system in Parkinson's disease.
    Mov Disord. 2011;26:216-22.
    PubMed     Text format     Related articles    Abstract available



  285. WEINTRAUB D
    A failure to communicate: Preliminary evidence for cortico-striatal dysconnection with pathological gambling in Parkinson's disease.
    Mov Disord. 2011;26:193-4.
    PubMed     Text format     Related articles   



  286. BARDINET E , Belaid H, Grabli D, Welter ML, et al
    Thalamic stimulation for tremor: can target determination be improved?
    Mov Disord. 2011;26:307-12.
    PubMed     Text format     Related articles    Abstract available



    January 2011
  287. BABA T , Takeda A, Kikuchi A, Nishio Y, et al
    Association of olfactory dysfunction and brain. Metabolism in Parkinson's disease.
    Mov Disord. 2011 Jan 31. doi: 10.1002/mds.23602.
    PubMed     Text format     Related articles    Abstract available



  288. ADLER CH , Shill HA, Beach TG
    Essential tremor and Parkinson's disease: Lack of a link.
    Mov Disord. 2011 Jan 31. doi: 10.1002/mds.23509.
    PubMed     Text format     Related articles   



  289. CILIA R , Cho SS, van Eimeren T, Marotta G, et al
    Pathological gambling in patients with Parkinson's disease is associated with fronto-striatal disconnection: A path modeling analysis.
    Mov Disord. 2011 Jan 31. doi: 10.1002/mds.23480.
    PubMed     Text format     Related articles    Abstract available



  290. SAUVAGEOT N , Vaillant M, Diederich NJ
    Reduced sympathetically driven heart rate variability during sleep in Parkinson's disease: A case-control polysomnography-based study.
    Mov Disord. 2011 Jan 31. doi: 10.1002/mds.23479.
    PubMed     Text format     Related articles    Abstract available



  291. GERLACH OH , Winogrodzka A, Weber WE
    Clinical problems in the hospitalized Parkinson's disease patient: Systematic review.
    Mov Disord. 2011 Jan 31. doi: 10.1002/mds.23449.
    PubMed     Text format     Related articles    Abstract available



  292. AZIZ NA , Pijl H, Frolich M, Roelfsema F, et al
    Leptin, adiponectin, and resistin secretion and diurnal rhythmicity are unaltered in Parkinson's disease.
    Mov Disord. 2011 Jan 26. doi: 10.1002/mds.23463.
    PubMed     Text format     Related articles   



  293. EGGERS C , Kahraman D, Fink GR, Schmidt M, et al
    Akinetic-rigid and tremor-dominant Parkinson's disease patients show different patterns of FP-CIT Single photon emission computed tomography.
    Mov Disord. 2011 Jan 24. doi: 10.1002/mds.23468.
    PubMed     Text format     Related articles    Abstract available



  294. MARTINEZ-MARTIN P , Rodriguez-Blazquez C, Kurtis MM, Chaudhuri KR, et al
    The impact of non-motor symptoms on health-related quality of life of patients with Parkinson's disease.
    Mov Disord. 2011 Jan 24. doi: 10.1002/mds.23462.
    PubMed     Text format     Related articles    Abstract available



  295. GUIDUBALDI A , Fasano A, Ialongo T, Piano C, et al
    Botulinum toxin A versus B in sialorrhea: A prospective, randomized, double-blind, crossover pilot study in patients with amyotrophic lateral sclerosis or Parkinson's disease.
    Mov Disord. 2011 Jan 21. doi: 10.1002/mds.23473.
    PubMed     Text format     Related articles    Abstract available



  296. SONG YJ , Huang Y, Halliday GM
    Clinical correlates of similar pathologies in parkinsonian syndromes.
    Mov Disord. 2011 Jan 21. doi: 10.1002/mds.23336.
    PubMed     Text format     Related articles    Abstract available



  297. FABBRINI G , Merello M, Evans AH, Lees AJ, et al
    Progressive parkinsonism, oculomotor abnormalities and autonomic dysfunction: Clinicopathological case.
    Mov Disord. 2011.
    PubMed     Text format     Related articles    Abstract available



  298. WICKREMARATCHI MM , Knipe MD, Sastry BS, Morgan E, et al
    The motor phenotype of Parkinson's disease in relation to age at Onset.
    Mov Disord. 2011.
    PubMed     Text format     Related articles    Abstract available



  299. SCHICKS J , Synofzik M, Petursson H, Huttenlocher J, et al
    Atypical juvenile parkinsonism in a consanguineous SPG15 family.
    Mov Disord. 2011.
    PubMed     Text format     Related articles   



  300. LORENZO-BETANCOR O , Samaranch L, Garcia-Martin E, Cervantes S, et al
    LINGO1 gene analysis in Parkinson's disease phenotypes.
    Mov Disord. 2011.
    PubMed     Text format     Related articles    Abstract available



  301. FRIEDMAN J
    Neuropsychiatric symptoms in Parkinson's disease.
    Mov Disord. 2011;26:191.
    PubMed     Text format     Related articles   



  302. AARSLAND D , Marsh L, Schrag A
    Reply: Neuropsychiatric symptoms in Parkinson's disease.
    Mov Disord. 2011;26:191-2.
    PubMed     Text format     Related articles   



  303. GRABER S , Liepelt-Scarfone I, Brussel T, Schweitzer K, et al
    Self estimated quality of life in monogenetic Parkinson's disease.
    Mov Disord. 2011;26:187-8.
    PubMed     Text format     Related articles   



  304. RODRIGUES B , Nobrega AC, Sampaio M, Argolo N, et al
    Silent saliva aspiration in Parkinson's disease.
    Mov Disord. 2011;26:138-41.
    PubMed     Text format     Related articles    Abstract available



  305. TUCK KK , Yeow TC, Morris JG, Baker F, et al
    The use of Fogs' test to assess associated movements in Parkinsonism, dystonia, and controls.
    Mov Disord. 2011;26:121-4.
    PubMed     Text format     Related articles    Abstract available



  306. TRENKWALDER C , Kies B, Rudzinska M, Fine J, et al
    Rotigotine effects on early morning motor function and sleep in Parkinson's disease: A double-blind, randomized, placebo-controlled study (RECOVER).
    Mov Disord. 2011;26:90-9.
    PubMed     Text format     Related articles    Abstract available



  307. VAN ROODEN SM , Colas F, Martinez-Martin P, Visser M, et al
    Clinical subtypes of Parkinson's disease.
    Mov Disord. 2011;26:51-8.
    PubMed     Text format     Related articles    Abstract available



  308. O'SULLIVAN SS , Johnson M, Williams DR, Revesz T, et al
    The effect of drug treatment on neurogenesis in Parkinson's disease.
    Mov Disord. 2011;26:45-50.
    PubMed     Text format     Related articles    Abstract available



  309. BARTUS RT , Herzog CD, Chu Y, Wilson A, et al
    Bioactivity of AAV2-neurturin gene therapy (CERE-120): Differences between Parkinson's disease and nonhuman primate brains.
    Mov Disord. 2011;26:27-36.
    PubMed     Text format     Related articles    Abstract available



  310. HALLIDAY GM , Stevens CH
    Glia: Initiators and progressors of pathology in Parkinson's disease.
    Mov Disord. 2011;26:6-17.
    PubMed     Text format     Related articles    Abstract available



  311. LEWIS TB , Standaert DG
    Parkinson's disease, primates, and gene therapy: Vive la difference?
    Mov Disord. 2011;26:2-3.
    PubMed     Text format     Related articles   



  312. GHAZAVI F , Fazlali Z, Banihosseini SS, Hosseini SR, et al
    PRKN, DJ-1, and PINK1 screening identifies novel splice site mutation in PRKN and two novel DJ-1 mutations.
    Mov Disord. 2011;26:80-9.
    PubMed     Text format     Related articles    Abstract available



  313. STERN G
    Why catechol?
    Mov Disord. 2011;26:24-6.
    PubMed     Text format     Related articles    Abstract available



  314. MAETZLER W , Schmid SP, Wurster I, Liepelt I, et al
    Reduced but not oxidized cerebrospinal fluid glutathione levels are lowered in Lewy body diseases.
    Mov Disord. 2011;26:176-81.
    PubMed     Text format     Related articles    Abstract available



    December 2010
  315. OGAKI K , Motoi Y, Li Y, Tomiyama H, et al
    Visual grasping in frontotemporal dementia and parkinsonism linked to chromosome 17 (microtubule-associated with protein tau): A comparison of N-Isopropyl-p-[(123)I]-iodoamphetamine brain perfusion single photon emission computed tomography analysis w
    Mov Disord. 2010.
    PubMed     Text format     Related articles   



  316. LEWIS TB , Standaert DG
    Parkinson's disease, primates, and gene therapy: Vive la difference?
    Mov Disord. 2010.
    PubMed     Text format     Related articles   



  317. LONGONI G , Agosta F, Kostic VS, Stojkovic T, et al
    MRI measurements of brainstem structures in patients with Richardson's syndrome, progressive supranuclear palsy-parkinsonism, and Parkinson's disease.
    Mov Disord. 2010.
    PubMed     Text format     Related articles    Abstract available



  318. PERROTTA A , Sandrini G, Serrao M, Buscone S, et al
    Facilitated temporal summation of pain at spinal level in Parkinson's disease.
    Mov Disord. 2010.
    PubMed     Text format     Related articles    Abstract available



  319. SIDEROWF A , Jennings D
    Erratum: Cardiac denervation in rapid eye movement sleep behavior disorder and Parkinson's disease: Getting to the heart of the matter.
    Mov Disord. 2010;25:2900.
    PubMed     Text format     Related articles   



  320. ONDO WG , Shinawi L, Moore S
    Comparison of orally dissolving carbidopa/levodopa (Parcopa) to conventional oral carbidopa/levodopa: A single-dose, double-blind, double-dummy, placebo-controlled, crossover trial.
    Mov Disord. 2010;25:2724-7.
    PubMed     Text format     Related articles    Abstract available



  321. EBERSBACH G , Gunkel M
    Posturography reflects clinical imbalance in Parkinson's disease.
    Mov Disord. 2010.
    PubMed     Text format     Related articles    Abstract available



  322. GRABER S , Liepelt-Scarfone I, Brussel T, Schweitzer K, et al
    Self estimated quality of life in monogenetic Parkinson's disease.
    Mov Disord. 2010.
    PubMed     Text format     Related articles   



  323. SCHOFIELD EC , Hodges JR, Macdonald V, Cordato NJ, et al
    Cortical atrophy differentiates Richardson's syndrome from the parkinsonian form of progressive supranuclear palsy.
    Mov Disord. 2010.
    PubMed     Text format     Related articles    Abstract available



  324. STATHIS P , Konitsiotis S, Tagaris G, Peterson D, et al
    Levetiracetam for the management of levodopa-induced dyskinesias in Parkinson's disease.
    Mov Disord. 2010.
    PubMed     Text format     Related articles    Abstract available



  325. MOISAN F , Spinosi J, Dupupet JL, Delabre L, et al
    The relation between type of farming and prevalence of Parkinson's disease among agricultural workers in five french districts.
    Mov Disord. 2010.
    PubMed     Text format     Related articles    Abstract available



  326. CHUNG SJ , Armasu SM, Biernacka JM, Lesnick TG, et al
    Common variants in PARK loci and related genes and Parkinson's disease.
    Mov Disord. 2010.
    PubMed     Text format     Related articles    Abstract available



  327. NAZIR T , Thomson AM
    Domestic violence and mistreatment in patients with parkinsonism: Case reports, mechanisms, and discussion.
    Mov Disord. 2010.
    PubMed     Text format     Related articles   



  328. BENINCASA D , Pellicano C, Fanciulli A, Pontieri FE, et al
    Bupropion abates dopamine agonist-mediated compulsive behaviors in Parkinson's disease.
    Mov Disord. 2010.
    PubMed     Text format     Related articles   



  329. DALAKER TO , Zivadinov R, Ramasamy DP, Beyer MK, et al
    Ventricular enlargement and mild cognitive impairment in early Parkinson's disease.
    Mov Disord. 2010.
    PubMed     Text format     Related articles    Abstract available



  330. ROCHESTER L , Baker K, Nieuwboer A, Burn D, et al
    Targeting dopa-sensitive and dopa-resistant gait dysfunction in Parkinson's disease: Selective responses to internal and external cues.
    Mov Disord. 2010.
    PubMed     Text format     Related articles    Abstract available



  331. TINAZ S , Courtney MG, Stern CE
    Focal cortical and subcortical atrophy in early Parkinson's disease.
    Mov Disord. 2010.
    PubMed     Text format     Related articles    Abstract available



  332. PISANI V , Madeo G, Tassone A, Sciamanna G, et al
    Homeostatic changes of the endocannabinoid system in Parkinson's disease.
    Mov Disord. 2010.
    PubMed     Text format     Related articles    Abstract available



    November 2010
  333. BARTUS RT , Herzog CD, Chu Y, Wilson A, et al
    Bioactivity of AAV2-neurturin gene therapy (CERE-120): Differences between Parkinson's disease and nonhuman primate brains.
    Mov Disord. 2010.
    PubMed     Text format     Related articles    Abstract available



  334. TRENKWALDER C , Kies B, Rudzinska M, Fine J, et al
    Rotigotine effects on early morning motor function and sleep in Parkinson's disease: A double-blind, randomized, placebo-controlled study (RECOVER).
    Mov Disord. 2010.
    PubMed     Text format     Related articles    Abstract available



  335. O'SULLIVAN SS , Johnson M, Williams DR, Revesz T, et al
    The effect of drug treatment on neurogenesis in Parkinson's disease.
    Mov Disord. 2010.
    PubMed     Text format     Related articles    Abstract available



  336. VAN ROODEN SM , Colas F, Martinez-Martin P, Visser M, et al
    Clinical subtypes of Parkinson's disease.
    Mov Disord. 2010.
    PubMed     Text format     Related articles    Abstract available



  337. RODRIGUES B , Nobrega AC, Sampaio M, Argolo N, et al
    Silent saliva aspiration in Parkinson's disease.
    Mov Disord. 2010.
    PubMed     Text format     Related articles    Abstract available



  338. TOMLINSON CL , Stowe R, Patel S, Rick C, et al
    Systematic review of levodopa dose equivalency reporting in Parkinson's disease.
    Mov Disord. 2010;25:2649-53.
    PubMed     Text format     Related articles    Abstract available



  339. FOSTER ER , Campbell MC, Burack MA, Hartlein J, et al
    Amyloid imaging of Lewy body-associated disorders.
    Mov Disord. 2010;25:2516-23.
    PubMed     Text format     Related articles    Abstract available



  340. TUCK KK , Yeow TC, Morris JG, Baker F, et al
    The use of Fogs' test to assess associated movements in Parkinsonism, dystonia, and controls.
    Mov Disord. 2010.
    PubMed     Text format     Related articles    Abstract available



  341. SKODDA S , Flasskamp A, Schlegel U
    Instability of syllable repetition in Parkinson's disease-Influence of levodopa and deep brain stimulation.
    Mov Disord. 2010.
    PubMed     Text format     Related articles    Abstract available



  342. IVAN R , Irena R
    Pathology of vessels supplying the brain in patients with Parkinson's disease.
    Mov Disord. 2010.
    PubMed     Text format     Related articles   



  343. PONCE FA , Lozano AM
    The most cited works in Parkinson's disease.
    Mov Disord. 2010.
    PubMed     Text format     Related articles    Abstract available



  344. AARSLAND D , Marsh L, Schrag A
    Reply: Neuropsychiatric symptoms in Parkinson's disease.
    Mov Disord. 2010.
    PubMed     Text format     Related articles   



  345. FRIEDMAN J
    Neuropsychiatric symptoms in Parkinson's disease.
    Mov Disord. 2010.
    PubMed     Text format     Related articles   



    October 2010
  346. ROSELLI F , Pisciotta N, Aniello M, Gigante A, et al
    Erratum: Midbrain SERT in degenerative parkinsonisms: A 123I-FP-CIT SPECT study.
    Mov Disord. 2010;25:2478.
    PubMed     Text format     Related articles   



  347. EBERSBACH G , Ebersbach A, Edler D, Kaufhold O, et al
    Erratum: Comparing exercie in Parkinson's disease-The Berlin LSVT(R)BIG study.
    Mov Disord. 2010;25:2478.
    PubMed     Text format     Related articles   



  348. BEISKE AG , Loge JH, Hjermstad MJ, Svensson Phd E, et al
    Fatigue in Parkinson's disease: Prevalence and associated factors.
    Mov Disord. 2010;25:2456-60.
    PubMed     Text format     Related articles    Abstract available



  349. FROSINI D , Pesaresi I, Cosottini M, Belmonte G, et al
    Parkinson's Disease and pathological gambling: Results from a functional MRI study.
    Mov Disord. 2010;25:2449-53.
    PubMed     Text format     Related articles    Abstract available



  350. KISHORE A , Rao R, Krishnan S, Panikar D, et al
    Long-term stability of effects of subthalamic stimulation in Parkinson's disease: Indian Experience.
    Mov Disord. 2010;25:2438-44.
    PubMed     Text format     Related articles    Abstract available



  351. VALAPPIL RA , Black JE, Broderick MJ, Carrillo O, et al
    Exploring the electrocardiogram as a potential tool to screen for premotor Parkinson's disease.
    Mov Disord. 2010;25:2296-303.
    PubMed     Text format     Related articles    Abstract available



  352. SIDEROWF A , Jennings D
    Cardiac denervation in rapid eye movement sleep behavior disorder and Parkinson's disease: Getting to the heart of the matter.
    Mov Disord. 2010;25:2269-71.
    PubMed     Text format     Related articles   



  353. FUNAYAMA M , Tomiyama H, Wu RM, Ogaki K, et al
    Rapid screening of ATP13A2 variant with high-resolution melting analysis.
    Mov Disord. 2010;25:2434-7.
    PubMed     Text format     Related articles    Abstract available



  354. ZAIDEL A , Bergman H, Ritov Y, Md ZI, et al
    Levodopa and subthalamic deep brain stimulation responses are not congruent.
    Mov Disord. 2010;25:2379-86.
    PubMed     Text format     Related articles    Abstract available



  355. POSTUMA RB , Lanfranchi PA, Blais H, Gagnon JF, et al
    Cardiac autonomic dysfunction in idiopathic REM sleep behavior disorder.
    Mov Disord. 2010;25:2304-10.
    PubMed     Text format     Related articles    Abstract available



  356. GUIMARAES J , Vieira-Coelho A, Rosas MJ, Moura E, et al
    Acute renal failure in patients with bilateral deep brain stimulation.
    Mov Disord. 2010;25:2462-4.
    PubMed     Text format     Related articles   



  357. VUCCKOVIC MG , Li Q, Fisher B, Nacca A, et al
    Exercise elevates dopamine D2 receptor in a mouse model of Parkinson's disease: In vivo imaging with [(18)F]fallypride.
    Mov Disord. 2010.
    PubMed     Text format     Related articles    Abstract available



  358. MEPPELINK AM , Nyman R, van Laar T, Drent M, et al
    Transcutaneous port for continuous duodenal levodopa/carbidopa administration in Parkinson's disease.
    Mov Disord. 2010.
    PubMed     Text format     Related articles    Abstract available



  359. ERRO ME , Munoz R, Zandio B, Mayor S, et al
    Reversible Parkinsonism after accidental oral intake of mancozeb.
    Mov Disord. 2010.
    PubMed     Text format     Related articles   



  360. LLEBARIA G , Pagonabarraga J, Martinez-Corral M, Garcia-Sanchez C, et al
    Neuropsychological correlates of mild to severe hallucinations in Parkinson's disease.
    Mov Disord. 2010.
    PubMed     Text format     Related articles    Abstract available



  361. AARSLAND D , Muniz G, Matthews F
    Nonlinear decline of mini-mental state examination in Parkinson's disease.
    Mov Disord. 2010.
    PubMed     Text format     Related articles    Abstract available



  362. SANTOS-GARCIA D , Macias M, Llaneza M, Grande M, et al
    Serum vitamin B(12) and folate levels in Parkinson's disease patients treated with duodenal levodopa infusion.
    Mov Disord. 2010.
    PubMed     Text format     Related articles   



  363. SUBRAMANIAN L , Hindle JV, Jackson MC, Linden DE, et al
    Dopamine boosts memory for angry faces in Parkinson's disease.
    Mov Disord. 2010.
    PubMed     Text format     Related articles    Abstract available



  364. DELLAPINA E , Gerdelat-Mas A, Ory-Magne F, Pourcel L, et al
    Apomorphine effect on pain threshold in Parkinson's disease: A clinical and positron emission tomography study.
    Mov Disord. 2010.
    PubMed     Text format     Related articles    Abstract available



  365. YEH IJ , Tsang EW, Hamani C, Moro E, et al
    Somatosensory evoked potentials recorded from the human pedunculopontine nucleus region.
    Mov Disord. 2010;25:2076-83.
    PubMed     Text format     Related articles    Abstract available



  366. LI H , Zhang M, Chen L, Zhang J, et al
    Nonmotor symptoms are independently associated with impaired health-related quality of life in Chinese patients with Parkinson's disease.
    Mov Disord. 2010.
    PubMed     Text format     Related articles    Abstract available



  367. BARICHELLA M , Madio C, Cassani E, Magris C, et al
    Oral high-calorie, low-protein supplements in a Parkinson's disease patient: A case report.
    Mov Disord. 2010.
    PubMed     Text format     Related articles   



  368. SKODDA S , Flasskamp A, Schlegel U
    Instability of syllable repetition as a marker of disease progression in Parkinson's disease: A longitudinal study.
    Mov Disord. 2010.
    PubMed     Text format     Related articles    Abstract available



  369. LEE JY , Cho J, Lee EK, Park SS, et al
    Differential genetic susceptibility in diphasic and peak-dose dyskinesias in Parkinson's disease.
    Mov Disord. 2010.
    PubMed     Text format     Related articles    Abstract available



  370. DI LAZZARO V , Pilato F, Granone P, Sestito A, et al
    Shortness of breath in a Parkinson's disease patient.
    Mov Disord. 2010.
    PubMed     Text format     Related articles   



  371. YOUNG TL , Granic A, Yu Chen T, Haley CB, et al
    Everyday reasoning abilities in persons with Parkinson's disease.
    Mov Disord. 2010.
    PubMed     Text format     Related articles    Abstract available



  372. DJALDETTI R , Lorberboym M, Karmon Y, Treves TA, et al
    Residual striatal dopaminergic nerve terminals in very long-standing Parkinson's disease: A single photon emission computed tomography imaging study.
    Mov Disord. 2010.
    PubMed     Text format     Related articles    Abstract available



  373. KLOSTERMANN F , Wahl M, Marzinzik F, Vesper J, et al
    Speed effects of deep brain stimulation for Parkinson's disease.
    Mov Disord. 2010.
    PubMed     Text format     Related articles    Abstract available



  374. LOPEZ IC , Ruiz PJ, Del Pozo SV, Bernardos VS, et al
    Motor complications in Parkinson's disease: Ten year follow-up study.
    Mov Disord. 2010.
    PubMed     Text format     Related articles    Abstract available



  375. HOGL B , Arnulf I, Comella C, Ferreira J, et al
    Scales to assess sleep impairment in Parkinson's disease: Critique and recommendations.
    Mov Disord. 2010.
    PubMed     Text format     Related articles    Abstract available



  376. ARABIA G , Morelli M, Paglionico S, Novellino F, et al
    An magnetic resonance imaging T2*-weighted sequence at short echo time to detect putaminal hypointensity in Parkinsonisms.
    Mov Disord. 2010.
    PubMed     Text format     Related articles    Abstract available



  377. VACHEROT F , Attarian S, Vaugoyeau M, Azulay JP, et al
    A motor cortex excitability and gait analysis on Parkinsonian patients.
    Mov Disord. 2010.
    PubMed     Text format     Related articles    Abstract available



  378. MULLER B , Larsen JP, Wentzel-Larsen T, Skeie GO, et al
    Autonomic and sensory symptoms and signs in incident, untreated Parkinson's disease: Frequent but mild.
    Mov Disord. 2010.
    PubMed     Text format     Related articles    Abstract available



  379. MILLER IN , Cronin-Golomb A
    Gender differences in Parkinson's disease: Clinical characteristics and cognition.
    Mov Disord. 2010.
    PubMed     Text format     Related articles    Abstract available



  380. KIEBURTZ K
    Twice-daily, low-dose pramipexole in early Parkinson's disease: A randomized, placebo-controlled trial.
    Mov Disord. 2010.
    PubMed     Text format     Related articles    Abstract available



  381. ALBANESE A , Lalli S
    Distinguishing scan without evidence of dopaminergic depletion patients with asymmetric resting tremor from Parkinson's disease: A clinical diagnosis of dystonia is required.
    Mov Disord. 2010.
    PubMed     Text format     Related articles   



  382. DUJARDIN K , Dubois B, Tison F, Durif F, et al
    Parkinson's disease dementia can be easily detected in routine clinical practice.
    Mov Disord. 2010.
    PubMed     Text format     Related articles    Abstract available



  383. MEPPELINK AM , de Jong BM, Teune LK, van Laar T, et al
    Regional cortical grey matter loss in Parkinson's disease without dementia is independent from visual hallucinations.
    Mov Disord. 2010.
    PubMed     Text format     Related articles    Abstract available



  384. GALLAGHER DA , Lees AJ, Schrag A
    What are the most important nonmotor symptoms in patients with Parkinson's disease and are we missing them?
    Mov Disord. 2010.
    PubMed     Text format     Related articles    Abstract available



    September 2010
  385. HOOGLAND J , de Bie RM, Williams-Gray CH, Muslimovic D, et al
    Catechol-O-methyltransferase val158met and cognitive function in Parkinson's disease.
    Mov Disord. 2010.
    PubMed     Text format     Related articles    Abstract available



  386. HUSSL A , Mahlknecht P, Scherfler C, Esterhammer R, et al
    Diagnostic accuracy of the magnetic resonance Parkinsonism index and the midbrain-to-pontine area ratio to differentiate progressive supranuclear palsy from Parkinson's disease and the Parkinson variant of multiple system atrophy.
    Mov Disord. 2010.
    PubMed     Text format     Related articles    Abstract available



  387. CHOU KL , Amick MM, Brandt J, Camicioli R, et al
    A recommended scale for cognitive screening in clinical trials of Parkinson's disease.
    Mov Disord. 2010.
    PubMed     Text format     Related articles    Abstract available



  388. SECHI G
    Reduced glutathione and Parkinson's disease.
    Mov Disord. 2010.
    PubMed     Text format     Related articles   




  389. Abstracts of the 2nd World Parkinson Congress. September 28-October 1, 2010.
    Mov Disord. 2010;25 Suppl 3:S569-726.
    PubMed     Text format     Related articles   



  390. OLANOW CW , Kieburtz K
    Defining disease-modifying therapies for PD--a road map for moving forward.
    Mov Disord. 2010;25:1774-9.
    PubMed     Text format     Related articles    Abstract available



  391. SHAHAR A , Patel KV, Semba RD, Bandinelli S, et al
    Plasma selenium is positively related to performance in neurological tasks assessing coordination and motor speed.
    Mov Disord. 2010;25:1909-15.
    PubMed     Text format     Related articles    Abstract available



  392. WATANABE H , Ito M, Fukatsu H, Senda J, et al
    Putaminal magnetic resonance imaging features at various magnetic field strengths in multiple system atrophy.
    Mov Disord. 2010;25:1916-23.
    PubMed     Text format     Related articles    Abstract available



  393. RODRIGUEZ-VIOLANTE M , Lees AJ, Cervantes-Arriaga A, Corona T, et al
    Use of smell test identification in Parkinson's disease in Mexico: A matched case-control study.
    Mov Disord. 2010.
    PubMed     Text format     Related articles    Abstract available



  394. SHINO MY , McGuire V, Van Den Eeden SK, Tanner CM, et al
    Familial aggregation of Parkinson's disease in a multiethnic community-based case-control study.
    Mov Disord. 2010.
    PubMed     Text format     Related articles    Abstract available



  395. CHOU KL , Koeppe RA, Bohnen NI
    Rhinorrhea: A common nondopaminergic feature of Parkinson's disease.
    Mov Disord. 2010.
    PubMed     Text format     Related articles    Abstract available



  396. GRACIELA CM , Claudia P, Eduardo MF, Beatriz RG, et al
    Alpha-synuclein immunoreactivity in minor salivary gland biopsies of Parkinson's disease patients.
    Mov Disord. 2010.
    PubMed     Text format     Related articles   



  397. DORSEY ER , Voss TS, Shprecher DR, Deuel LM, et al
    A U.S. survey of patients with Parkinson's disease: Satisfaction with medical care and support groups.
    Mov Disord. 2010.
    PubMed     Text format     Related articles    Abstract available



  398. JOHNSTON TH , Fox SH, Piggott MJ, Savola JM, et al
    The alpha(2) adrenergic antagonist fipamezole improves quality of levodopa action in Parkinsonian primates.
    Mov Disord. 2010.
    PubMed     Text format     Related articles    Abstract available



  399. SERRANO-DUENAS M , Calero B, Serrano S, Serrano M, et al
    Metric properties of the mini-mental Parkinson and SCOPA-COG scales for rating cognitive deterioration in Parkinson's disease.
    Mov Disord. 2010.
    PubMed     Text format     Related articles    Abstract available



  400. MONTINE TJ , Shi M, Quinn JF, Peskind ER, et al
    CSF Abeta(42) and tau in Parkinson's disease with cognitive impairment.
    Mov Disord. 2010.
    PubMed     Text format     Related articles    Abstract available



  401. KINGSBURY AE , Bandopadhyay R, Silveira-Moriyama L, Ayling H, et al
    Brain stem pathology in Parkinson's disease: An evaluation of the Braak staging model.
    Mov Disord. 2010.
    PubMed     Text format     Related articles    Abstract available



  402. SIMUNI T , Borushko E, Avram MJ, Miskevics S, et al
    Tolerability of isradipine in early Parkinson's disease: A pilot dose escalation study.
    Mov Disord. 2010.
    PubMed     Text format     Related articles    Abstract available



  403. YUCEL A , Kusbeci OY
    Magnetic resonance imaging findings of shoulders in Parkinson's disease.
    Mov Disord. 2010.
    PubMed     Text format     Related articles    Abstract available



  404. KHADEM NR , Nirenberg MJ
    Carbidopa/levodopa pharmacy errors in Parkinson's disease.
    Mov Disord. 2010.
    PubMed     Text format     Related articles    Abstract available



  405. SEKINE T , Kagaya H, Funayama M, Li Y, et al
    Clinical course of the first Asian family with Parkinsonism related to SNCA triplication.
    Mov Disord. 2010.
    PubMed     Text format     Related articles    Abstract available



  406. SILVEIRA-MORIYAMA L , Munhoz RP, de J Carvalho M, Raskin S, et al
    Olfactory heterogeneity in LRRK2 related Parkinsonism.
    Mov Disord. 2010.
    PubMed     Text format     Related articles    Abstract available



  407. SAUNDERS-PULLMAN R , Barrett MJ, Stanley KM, Luciano MS, et al
    LRRK2 G2019S mutations are associated with an increased cancer risk in Parkinson disease.
    Mov Disord. 2010.
    PubMed     Text format     Related articles    Abstract available



  408. NAISMITH SL , Pereira M, Shine JM, Lewis SJ, et al
    How well do caregivers detect mild cognitive change in Parkinson's disease?
    Mov Disord. 2010.
    PubMed     Text format     Related articles    Abstract available



  409. COSTA J , Gonzalez HA, Valldeoriola F, Gaig C, et al
    Nonlinear dynamic analysis of oscillatory repetitive movements in Parkinson's disease and essential tremor.
    Mov Disord. 2010.
    PubMed     Text format     Related articles    Abstract available



    August 2010
  410. DEUEL LM , Chesire AM, Eason S, Como PG, et al
    Reply: An exploration of the burden experienced by spousal caregivers of individuals with Parkinson's disease.
    Mov Disord. 2010.
    PubMed     Text format     Related articles   



  411. ASHKAN K , Hettige S, Samuel M
    Reply: Safe and effective deep brain stimulation for Parkinson's disease in the context of HIV.
    Mov Disord. 2010.
    PubMed     Text format     Related articles   



  412. TISCH S , Brew BJ
    HIV, HAART, and Parkinson's disease: Co-incidence or pathogenetic link?
    Mov Disord. 2010.
    PubMed     Text format     Related articles   



  413. CHEN R
    Repetitive transcranial magnetic stimulation as treatment for depression in Parkinson's disease.
    Mov Disord. 2010.
    PubMed     Text format     Related articles    Abstract available



  414. PAL E , Nagy F, Aschermann Z, Balazs E, et al
    The impact of left prefrontal repetitive transcranial magnetic stimulation on depression in Parkinson's disease: A randomized, double-blind, placebo-controlled study.
    Mov Disord. 2010.
    PubMed     Text format     Related articles    Abstract available



  415. VERBAAN D , van Rooden SM, van Hilten JJ, Rijsman RM, et al
    Prevalence and clinical profile of restless legs syndrome in Parkinson's disease.
    Mov Disord. 2010.
    PubMed     Text format     Related articles    Abstract available



  416. GAO X , Schwarzschild MA, O'Reilly EJ, Wang H, et al
    Restless legs syndrome and Parkinson's disease in men.
    Mov Disord. 2010.
    PubMed     Text format     Related articles    Abstract available



  417. CALLAGHAN RC , Cunningham JK, Sajeev G, Kish SJ, et al
    Incidence of Parkinson's disease among hospital patients with methamphetamine-use disorders.
    Mov Disord. 2010.
    PubMed     Text format     Related articles    Abstract available



  418. COLE MH , Silburn PA, Wood JM, Worringham CJ, et al
    Falls in Parkinson's disease: Kinematic evidence for impaired head and trunk control.
    Mov Disord. 2010.
    PubMed     Text format     Related articles    Abstract available



  419. PRODOEHL J , Spraker M, Corcos D, Comella C, et al
    Blood oxygenation level-dependent activation in basal ganglia nuclei relates to specific symptoms in de novo Parkinson's disease.
    Mov Disord. 2010.
    PubMed     Text format     Related articles    Abstract available



  420. RODRIGUEZ-FERREIRO J , Cuetos F, Herrera E, Menendez M, et al
    Cognitive impairment in Parkinson's disease without dementia.
    Mov Disord. 2010.
    PubMed     Text format     Related articles    Abstract available



  421. CHASTIN SF , Baker K, Jones D, Burn D, et al
    The pattern of habitual sedentary behavior is different in advanced Parkinson's disease.
    Mov Disord. 2010.
    PubMed     Text format     Related articles    Abstract available



  422. SERRANO-DUENAS M , Calero B, Serrano S, Serrano M, et al
    Psychometric attributes of the rating scale for gait evaluation in Parkinson's disease.
    Mov Disord. 2010.
    PubMed     Text format     Related articles    Abstract available



  423. HOLDEFER RN , Cohen BA, Greene KA
    Intraoperative local field recording for deep brain stimulation in Parkinson's disease and essential tremor.
    Mov Disord. 2010.
    PubMed     Text format     Related articles    Abstract available



  424. PECCI C , Rivas MJ, Moretti CM, Raina G, et al
    Use of complementary and alternative therapies in outpatients with Parkinson's disease in Argentina.
    Mov Disord. 2010.
    PubMed     Text format     Related articles    Abstract available



  425. DJAMSHIDIAN A , Jha A, O'Sullivan SS, Silveira-Moriyama L, et al
    Risk and learning in impulsive and nonimpulsive patients with Parkinson's disease.
    Mov Disord. 2010.
    PubMed     Text format     Related articles    Abstract available



  426. RUGBJERG K , Friis S, Jorgensen TL, Ritz B, et al
    Risk for Parkinson's disease among patients with osteoarthritis: A Danish cohort study.
    Mov Disord. 2010.
    PubMed     Text format     Related articles    Abstract available



  427. RUIZ-MARTINEZ J , Gorostidi A, Ibanez B, Alzualde A, et al
    Penetrance in Parkinson's disease related to the LRRK2 R1441G mutation in the Basque country (Spain).
    Mov Disord. 2010.
    PubMed     Text format     Related articles    Abstract available



  428. KERTELGE L , Bruggemann N, Schmidt A, Tadic V, et al
    Impaired sense of smell and color discrimination in monogenic and idiopathic Parkinson's disease.
    Mov Disord. 2010.
    PubMed     Text format     Related articles    Abstract available



  429. MAIDAN I , Plotnik M, Mirelman A, Weiss A, et al
    Heart rate changes during freezing of gait in patients with Parkinson's disease.
    Mov Disord. 2010.
    PubMed     Text format     Related articles    Abstract available



  430. JASINSKA-MYGA B , Kachergus J, Vilarino-Guell C, Wider C, et al
    Comprehensive sequencing of the LRRK2 gene in patients with familial Parkinson's disease from North Africa.
    Mov Disord. 2010.
    PubMed     Text format     Related articles    Abstract available



  431. LEE MS , Lyoo CH, Lee MJ, Sim J, et al
    Impaired finger dexterity in patients with parkinson's disease correlates with discriminative cutaneous sensory dysfunction.
    Mov Disord. 2010.
    PubMed     Text format     Related articles    Abstract available



  432. DAHODWALA N , Siderowf A, Stern M, Xie M, et al
    Reply: Racial differences in the diagnosis of Parkinson's disease-Not just a North American issue.
    Mov Disord. 2010.
    PubMed     Text format     Related articles   



  433. DOTCHIN C , Walker R
    Racial differences in the diagnosis of Parkinson's disease-Not just a North American issue.
    Mov Disord. 2010.
    PubMed     Text format     Related articles   



  434. GIL-NAVARRO S , Grandas F
    Dyskinesia-hyperpyrexia syndrome: Another Parkinson's disease emergency.
    Mov Disord. 2010.
    PubMed     Text format     Related articles   



  435. URBAN PP , Wellach I, Faiss S, Layer P, et al
    Subacute axonal neuropathy in Parkinson's disease with cobalamin and vitamin B6 deficiency under duodopa therapy.
    Mov Disord. 2010;25:1748-52.
    PubMed     Text format     Related articles    Abstract available



  436. GARDENER H , Gao X, Chen H, Schwarzschild MA, et al
    Prenatal and early life factors and risk of Parkinson's disease.
    Mov Disord. 2010;25:1560-7.
    PubMed     Text format     Related articles    Abstract available



  437. GHIGLIERI V , Picconi B, Calabresi P
    Direct and indirect pathways in levodopa-induced dyskinesia: a more complex matter than a network imbalance.
    Mov Disord. 2010;25:1527-9.
    PubMed     Text format     Related articles   



  438. BELUJON P , Lodge DJ, Grace AA
    Aberrant striatal plasticity is specifically associated with dyskinesia following levodopa treatment.
    Mov Disord. 2010;25:1568-76.
    PubMed     Text format     Related articles    Abstract available



  439. VITALE C , Santangelo G, Verde F, Amboni M, et al
    Exercise dependence induced by pramipexole in Parkinson's Disease-A Case Report.
    Mov Disord. 2010.
    PubMed     Text format     Related articles   



  440. FONOFF ET , de Oliveira YS, Driollet S, Garrido GJ, et al
    Pet findings in reversible improvement of olfactory dysfunction after STN stimulation in a Parkinson's disease patient.
    Mov Disord. 2010.
    PubMed     Text format     Related articles   



    July 2010
  441. DI GIACOPO R , Fasano A, Fenici R, Loria G, et al
    Rare and serious cardiac side effects during ropinirole titration.
    Mov Disord. 2010;25:1509-10.
    PubMed     Text format     Related articles   



  442. KLEINER-FISMAN G , Lozano A, Moro E, Poon YY, et al
    Long-term effect of unilateral pallidotomy on levodopa-induced dyskinesia.
    Mov Disord. 2010;25:1496-8.
    PubMed     Text format     Related articles    Abstract available



  443. PAISAN-RUIZ C , Guevara R, Federoff M, Hanagasi H, et al
    Early-onset L-dopa-responsive parkinsonism with pyramidal signs due to ATP13A2, PLA2G6, FBXO7 and spatacsin mutations.
    Mov Disord. 2010.
    PubMed     Text format     Related articles    Abstract available



  444. CEREDA E , Barichella M, Pedrolli C, Pezzoli G, et al
    Low-protein and protein-redistribution diets for Parkinson's disease patients with motor fluctuations: A systematic review.
    Mov Disord. 2010.
    PubMed     Text format     Related articles    Abstract available



  445. HAUSER RA , Schapira AH, Rascol O, Barone P, et al
    Randomized, double-blind, multicenter evaluation of pramipexole extended release once daily in early Parkinson's disease.
    Mov Disord. 2010.
    PubMed     Text format     Related articles    Abstract available



  446. SUNG HY , Kim JS, Lee KS, Kim YI, et al
    The prevalence and patterns of pharyngoesophageal dysmotility in patients with early stage Parkinson's disease.
    Mov Disord. 2010.
    PubMed     Text format     Related articles    Abstract available



  447. SCHWID SR , Bausch J, Oakes D, Schuchter L, et al
    Cancer incidence in a trial of an antiapoptotic agent for Parkinson's disease.
    Mov Disord. 2010.
    PubMed     Text format     Related articles    Abstract available



  448. SKEIE GO , Muller B, Haugarvoll K, Larsen JP, et al
    Differential effect of environmental risk factors on postural instability gait difficulties and tremor dominant Parkinson's disease.
    Mov Disord. 2010.
    PubMed     Text format     Related articles    Abstract available



  449. BOWER JH , Grossardt BR, Maraganore DM, Ahlskog JE, et al
    Anxious personality predicts an increased risk of Parkinson's disease.
    Mov Disord. 2010.
    PubMed     Text format     Related articles    Abstract available



  450. GILBERT RM , Fahn S, Mitsumoto H, Rowland LP, et al
    Parkinsonism and motor neuron diseases: Twenty-seven patients with diverse overlap syndromes.
    Mov Disord. 2010.
    PubMed     Text format     Related articles    Abstract available



  451. AASLY JO , Vilarino-Guell C, Dachsel JC, Webber PJ, et al
    Novel pathogenic LRRK2 p.Asn1437His substitution in familial Parkinson's disease.
    Mov Disord. 2010.
    PubMed     Text format     Related articles    Abstract available



  452. ARIAS P , Vivas J, Grieve KL, Cudeiro J, et al
    Controlled trial on the effect of 10 days low-frequency repetitive transcranial magnetic stimulation (rTMS) on motor signs in Parkinson's disease.
    Mov Disord. 2010.
    PubMed     Text format     Related articles    Abstract available



  453. ROSS OA , Wilhoite GJ, Bacon JA, Soto-Ortolaza A, et al
    LRRK2 variation and Parkinson's disease in African Americans.
    Mov Disord. 2010.
    PubMed     Text format     Related articles    Abstract available



  454. STOCCHI F , Zappia M, Dall'armi V, Kulisevsky J, et al
    Melevodopa/carbidopa effervescent formulation in the treatment of motor fluctuations in advanced Parkinson's disease.
    Mov Disord. 2010.
    PubMed     Text format     Related articles    Abstract available



  455. EBERSBACH G , Ebersbach A, Edler D, Kaufhold O, et al
    Comparing exercise in Parkinson's disease-The Berlin BIG Study.
    Mov Disord. 2010.
    PubMed     Text format     Related articles    Abstract available



  456. LOLEKHA P , Phanthumchinda K, Bhidayasiri R
    Prevalence and risk factors of Parkinson's disease in retired Thai traditional boxers.
    Mov Disord. 2010.
    PubMed     Text format     Related articles    Abstract available



  457. CUBO E , Tedejo RP, Rodriguez Mendez V, Lopez Pena MJ, et al
    Retina thickness in Parkinson's disease and essential tremor.
    Mov Disord. 2010.
    PubMed     Text format     Related articles   



  458. TROTTI LM , Bliwise DL
    No increased risk of obstructive sleep apnea in Parkinson's disease.
    Mov Disord. 2010.
    PubMed     Text format     Related articles    Abstract available



  459. STEPHENSON R , Houghton D, Sundarararjan S, Doty RL, et al
    Odor identification deficits are associated with increased risk of neuropsychiatric complications in patients with Parkinson's disease.
    Mov Disord. 2010.
    PubMed     Text format     Related articles    Abstract available



  460. ROSELLI F , Pisciotta NM, Pennelli M, Aniello MS, et al
    Midbrain SERT in degenerative parkinsonisms: A 123I-FP-CIT SPECT study.
    Mov Disord. 2010.
    PubMed     Text format     Related articles    Abstract available



  461. IBARRETXE-BILBAO N , Junque C, Marti MJ, Valldeoriola F, et al
    Olfactory impairment in Parkinson's disease and white matter abnormalities in central olfactory areas: A voxel-based diffusion tensor imaging study.
    Mov Disord. 2010.
    PubMed     Text format     Related articles    Abstract available



  462. KONO S , Ouchi Y, Terada T, Ida H, et al
    Functional brain imaging in glucocerebrosidase mutation carriers with and without Parkinsonism.
    Mov Disord. 2010.
    PubMed     Text format     Related articles    Abstract available



  463. LO RY , Tanner CM, Van Den Eeden SK, Albers KB, et al
    Comorbid cancer in Parkinson's disease.
    Mov Disord. 2010.
    PubMed     Text format     Related articles    Abstract available



  464. RASCOL O , Barone P, Hauser RA, Mizuno Y, et al
    Efficacy, safety, and tolerability of overnight switching from immediate- to once daily extended-release pramipexole in early Parkinson's disease.
    Mov Disord. 2010.
    PubMed     Text format     Related articles    Abstract available



  465. REIJNDERS JS , Scholtissen B, Weber WE, Aalten P, et al
    Neuroanatomical correlates of apathy in Parkinson's disease: A magnetic resonance imaging study using voxel-based morphometry.
    Mov Disord. 2010.
    PubMed     Text format     Related articles    Abstract available



  466. ROTONDO A , Bosco D, Plastino M, Consoli A, et al
    Clozapine for medication-related pathological gambling in Parkinson disease.
    Mov Disord. 2010.
    PubMed     Text format     Related articles   



  467. SIMON KC , Gao X, Chen H, Schwarzschild MA, et al
    Calcium channel blocker use and risk of Parkinson's disease.
    Mov Disord. 2010.
    PubMed     Text format     Related articles    Abstract available



  468. ESPAY AJ , Paviour DC, O'Sullivan JD, Schmidt RE, et al
    Juvenile levodopa-responsive Parkinsonism with early orobuccolingual dyskinesias and cognitive impairment.
    Mov Disord. 2010.
    PubMed     Text format     Related articles    Abstract available



  469. KANG SY , Wasaka T, Shamim EA, Auh S, et al
    Characteristics of the sequence effect in Parkinson's disease.
    Mov Disord. 2010.
    PubMed     Text format     Related articles    Abstract available



  470. NICOLETTI A , Pugliese P, Nicoletti G, Arabia G, et al
    Voluptuary habits and clinical subtypes of Parkinson's disease: The FRAGAMP case-control study.
    Mov Disord. 2010.
    PubMed     Text format     Related articles    Abstract available



  471. CARECCHIO M , Collini A, Comi C, Cantello R, et al
    Levodopa-induced belly dancer's dyskinesias in Parkinson's disease: Report of one case.
    Mov Disord. 2010.
    PubMed     Text format     Related articles   



  472. HORSTINK MW , Dekker MC, Montagna P, Bonifati V, et al
    Pallidopyramidal disease: a misnomer?
    Mov Disord. 2010;25:1109-15.
    PubMed     Text format     Related articles    Abstract available



  473. SPILDOOREN J , Vercruysse S, Desloovere K, Vandenberghe W, et al
    Freezing of gait in Parkinson's disease: The impact of dual-tasking and turning.
    Mov Disord. 2010.
    PubMed     Text format     Related articles    Abstract available



  474. CARDOSO EF , Fregni F, Maia FM, Melo LM, et al
    Abnormal visual activation in Parkinson's disease patients.
    Mov Disord. 2010.
    PubMed     Text format     Related articles    Abstract available



  475. ROD NH , Hansen J, Schernhammer E, Ritz B, et al
    Major life events and risk of Parkinson's disease.
    Mov Disord. 2010.
    PubMed     Text format     Related articles    Abstract available



    June 2010
  476. CALZETTI S , Negrotti A, Bonavina G, Angelini M, et al
    Restless legs syndrome and Parkinson's disease.
    Mov Disord. 2010.
    PubMed     Text format     Related articles   



  477. RAO H , Mamikonyan E, Detre JA, Siderowf AD, et al
    Decreased ventral striatal activity with impulse control disorders in Parkinson's disease.
    Mov Disord. 2010.
    PubMed     Text format     Related articles    Abstract available



  478. MENZA M , Dobkin RD, Marin H, Gara M, et al
    Treatment of insomnia in Parkinson's disease: A controlled trial of eszopiclone and placebo.
    Mov Disord. 2010.
    PubMed     Text format     Related articles    Abstract available



  479. MARTI M , Sarubbo S, Latini F, Cavallo M, et al
    Brain Interstitial Nociceptin/Orphanin FQ Levels are Elevated in Parkinson's Disease.
    Mov Disord. 2010.
    PubMed     Text format     Related articles    Abstract available



  480. GIUSEPPE F , Gabriella B, Davide U, Roberto M, et al
    Parkinson's disease rehabilitation: A pilot study with 1 year follow up.
    Mov Disord. 2010.
    PubMed     Text format     Related articles   



  481. SUSSMUTH SD , Uttner I, Landwehrmeyer B, Pinkhardt EH, et al
    Differential pattern of brain-specific CSF proteins tau and amyloid-beta in Parkinsonian syndromes.
    Mov Disord. 2010.
    PubMed     Text format     Related articles    Abstract available



  482. DANIELS C , Krack P, Volkmann J, Pinsker MO, et al
    Risk factors for executive dysfunction after subthalamic nucleus stimulation in Parkinson's disease.
    Mov Disord. 2010.
    PubMed     Text format     Related articles    Abstract available



  483. UBEDA-BANON I , Saiz-Sanchez D, de la Rosa-Prieto C, Mohedano-Moriano A, et al
    Staging of alpha-synuclein in the olfactory bulb in a model of Parkinson's disease: Cell types involved.
    Mov Disord. 2010.
    PubMed     Text format     Related articles    Abstract available



  484. SNOW BJ , Rolfe FL, Lockhart MM, Frampton CM, et al
    A double-blind, placebo-controlled study to assess the mitochondria-targeted antioxidant MitoQ as a disease-modifying therapy in Parkinson's disease.
    Mov Disord. 2010.
    PubMed     Text format     Related articles    Abstract available



  485. ROUAUD T , Dondaine T, Drapier S, Haegelen C, et al
    Pallidal stimulation in advanced Parkinson's patients with contraindications for subthalamic stimulation.
    Mov Disord. 2010.
    PubMed     Text format     Related articles    Abstract available



  486. HALL D , Pickler L, Riley K, Tassone F, et al
    Parkinsonism and cognitive decline in a fragile X mosaic male.
    Mov Disord. 2010.
    PubMed     Text format     Related articles   



  487. MARINELLI L , Perfetti B, Moisello C, Di Rocco A, et al
    Increased reaction time predicts visual learning deficits in Parkinson's disease.
    Mov Disord. 2010.
    PubMed     Text format     Related articles    Abstract available



  488. COFFEY MJ , Chou KL, Patil PG
    Catatonia during deep brain stimulator implantation complicated by intracranial hemorrhage.
    Mov Disord. 2010;25:1097-8.
    PubMed     Text format     Related articles   



  489. ROSA MM , Ferreira JJ, Coelho M, Freire R, et al
    Prescribing patterns of antiparkinsonian agents in Europe.
    Mov Disord. 2010;25:1053-60.
    PubMed     Text format     Related articles    Abstract available



  490. KWON DY , Seo WK, Yoon HK, Park MH, et al
    Transcranial brain sonography in Parkinson's disease with restless legs syndrome.
    Mov Disord. 2010.
    PubMed     Text format     Related articles    Abstract available



  491. BORGHERESI A , Espay AJ, Giovannelli F, Vanni P, et al
    Congenital mirror movements in Parkinson's disease: Clinical and neurophysiological observations.
    Mov Disord. 2010.
    PubMed     Text format     Related articles   



  492. SCHAPIRA AH , Albrecht S, Barone P, Comella CL, et al
    Rationale for delayed-start study of pramipexole in Parkinson's disease: The PROUD study.
    Mov Disord. 2010.
    PubMed     Text format     Related articles    Abstract available



  493. VITEK JL , Lyons KE, Bakay R, Benabid AL, et al
    Standard guidelines for publication of deep brain stimulation studies in Parkinson's disease (Guide4DBS-PD).
    Mov Disord. 2010.
    PubMed     Text format     Related articles    Abstract available



  494. DELVAL A , Snijders AH, Weerdesteyn V, Duysens JE, et al
    Objective detection of subtle freezing of gait episodes in Parkinson's disease.
    Mov Disord. 2010.
    PubMed     Text format     Related articles    Abstract available



  495. DORSEY ER , Deuel LM, Voss TS, Finnigan K, et al
    Increasing access to specialty care: A pilot, randomized controlled trial of telemedicine for Parkinson's disease.
    Mov Disord. 2010.
    PubMed     Text format     Related articles    Abstract available



    May 2010
  496. GONDIM FD , Costa HA, Taunay TC, de Oliveira GR, et al
    Transient amantadine-induced musical hallucinations in a patient with Parkinson's disease.
    Mov Disord. 2010.
    PubMed     Text format     Related articles   



  497. VILENSKY JA , Gilman S, McCall S
    A historical analysis of the relationship between encephalitis lethargica and postencephalitic parkinsonism: A complex rather than a direct relationship.
    Mov Disord. 2010.
    PubMed     Text format     Related articles    Abstract available



  498. ESPAY AJ , Vaughan JE, Marras C, Fowler R, et al
    Early versus delayed bilateral subthalamic deep brain stimulation for parkinson's disease: A decision analysis.
    Mov Disord. 2010.
    PubMed     Text format     Related articles    Abstract available



  499. SAUNDERS-PULLMAN R , Hagenah J, Dhawan V, Stanley K, et al
    Gaucher disease ascertained through a Parkinson's center: Imaging and clinical characterization.
    Mov Disord. 2010.
    PubMed     Text format     Related articles    Abstract available



  500. BARNIKOL TT , Pawelczyk NB, Barnikol UB, Kuhn J, et al
    Changes in apraxia after deep brain stimulation of the nucleus basalis Meynert in a patient with Parkinson dementia syndrome.
    Mov Disord. 2010.
    PubMed     Text format     Related articles   



  501. KAGI G , Klein C, Wood NW, Schneider SA, et al
    Nonmotor symptoms in Parkin gene-related parkinsonism.
    Mov Disord. 2010.
    PubMed     Text format     Related articles    Abstract available



  502. PINEAU F , Schupbach M, Corvol JC, Flamand-Rouviere C, et al
    Long-standing paraphilia induced by dopamine agonists in Parkinson's disease.
    Mov Disord. 2010;25:963-5.
    PubMed     Text format     Related articles   



  503. OKUN MS , Lang A, Jankovic J
    Reply: Based on the available randomized trial patients should say no to glutathione for Parkinson's disease.
    Mov Disord. 2010;25:961-2.
    PubMed     Text format     Related articles   



  504. HERSH BP , Earl NL, Hauser RA, Stacy M, et al
    Early treatment benefits of ropinirole prolonged release in Parkinson's disease patients with motor fluctuations.
    Mov Disord. 2010;25:927-31.
    PubMed     Text format     Related articles    Abstract available



  505. PISANI V , Moschella V, Bari M, Fezza F, et al
    Dynamic changes of anandamide in the cerebrospinal fluid of Parkinson's disease patients.
    Mov Disord. 2010;25:920-4.
    PubMed     Text format     Related articles    Abstract available



  506. DE PALMA G , Dick FD, Calzetti S, Scott NW, et al
    A case-control study of Parkinson's disease and tobacco use: gene-tobacco interactions.
    Mov Disord. 2010;25:912-9.
    PubMed     Text format     Related articles    Abstract available



  507. EGGERT K , Squillacote D, Barone P, Dodel R, et al
    Safety and efficacy of perampanel in advanced Parkinson's disease: a randomized, placebo-controlled study.
    Mov Disord. 2010;25:896-905.
    PubMed     Text format     Related articles    Abstract available



  508. EVANS AH , Lawrence AD, Cresswell SA, Katzenschlager R, et al
    Compulsive use of dopaminergic drug therapy in Parkinson's disease: reward and anti-reward.
    Mov Disord. 2010;25:867-76.
    PubMed     Text format     Related articles    Abstract available



  509. WATTS RL , Lyons KE, Pahwa R, Sethi K, et al
    Onset of dyskinesia with adjunct ropinirole prolonged-release or additional levodopa in early Parkinson's disease.
    Mov Disord. 2010;25:858-66.
    PubMed     Text format     Related articles    Abstract available



  510. DISSANAYAKA NN , Sellbach A, Matheson S, O'Sullivan JD, et al
    Anxiety disorders in Parkinson's disease: prevalence and risk factors.
    Mov Disord. 2010;25:838-45.
    PubMed     Text format     Related articles    Abstract available



  511. KEUS SH , Nijkrake MJ, Borm GF, Kwakkel G, et al
    The ParkinsonNet trial: design and baseline characteristics.
    Mov Disord. 2010;25:830-7.
    PubMed     Text format     Related articles    Abstract available



  512. NIJKRAKE MJ , Keus SH, Overeem S, Oostendorp RA, et al
    The ParkinsonNet concept: development, implementation and initial experience.
    Mov Disord. 2010;25:823-9.
    PubMed     Text format     Related articles    Abstract available



  513. FRIEDMAN JH , Alves G, Hagell P, Marinus J, et al
    Fatigue rating scales critique and recommendations by the Movement Disorders Society task force on rating scales for Parkinson's disease.
    Mov Disord. 2010;25:805-22.
    PubMed     Text format     Related articles    Abstract available



  514. KASTEN M , Weichert C, Lohmann K, Klein C, et al
    Clinical and demographic characteristics of PINK1 mutation carriers--a meta-analysis.
    Mov Disord. 2010;25:952-4.
    PubMed     Text format     Related articles   



  515. GAGNON JF , Postuma RB, Joncas S, Desjardins C, et al
    The Montreal Cognitive Assessment: a screening tool for mild cognitive impairment in REM sleep behavior disorder.
    Mov Disord. 2010;25:936-40.
    PubMed     Text format     Related articles    Abstract available



  516. POLITIS M , Wu K, Molloy S, G Bain P, et al
    Parkinson's disease symptoms: The patient's perspective.
    Mov Disord. 2010.
    PubMed     Text format     Related articles    Abstract available



  517. BENNINGER DH , Michel J, Waldvogel D, Candia V, et al
    REM sleep behavior disorder is not linked to postural instability and gait dysfunction in Parkinson.
    Mov Disord. 2010.
    PubMed     Text format     Related articles    Abstract available



  518. FASANO A , Pettorruso M, Ricciardi L, Conte G, et al
    Punding in Parkinson's disease: The impact of patient's awareness on diagnosis.
    Mov Disord. 2010.
    PubMed     Text format     Related articles   



  519. VILENSKY JA , Gilman S, McCall S
    Does the historical literature on encephalitis lethargica support a simple (direct) relationship with postencephalitic Parkinsonism?
    Mov Disord. 2010.
    PubMed     Text format     Related articles    Abstract available



    April 2010
  520. JEON BS , Lee KM
    Acupuncture for Parkinson's disease?
    Mov Disord. 2010;25:795-6.
    PubMed     Text format     Related articles   



  521. FENELON G , Soulas T, Zenasni F, de Langavant LC, et al
    The changing face of Parkinson's disease-associated psychosis: a cross-sectional study based on the new NINDS-NIMH criteria.
    Mov Disord. 2010;25:755-9.
    PubMed     Text format     Related articles    Abstract available



  522. CHAUDHURI KR , Prieto-Jurcynska C, Naidu Y, Mitra T, et al
    The nondeclaration of nonmotor symptoms of Parkinson's disease to health care professionals: an international study using the nonmotor symptoms questionnaire.
    Mov Disord. 2010;25:697-701.
    PubMed     Text format     Related articles    Abstract available



  523. APOSTOLOVA LG , Beyer M, Green AE, Hwang KS, et al
    Hippocampal, caudate, and ventricular changes in Parkinson's disease with and without dementia.
    Mov Disord. 2010;25:687-8.
    PubMed     Text format     Related articles    Abstract available



  524. KRANICK SM , Mowry EM, Colcher A, Horn S, et al
    Movement disorders and pregnancy: a review of the literature.
    Mov Disord. 2010;25:665-71.
    PubMed     Text format     Related articles    Abstract available



  525. GANCHER S , Nutt J
    Tolerance to apomorphine develops and reverses rapidly.
    Mov Disord. 2010;25:797.
    PubMed     Text format     Related articles   



  526. JANKOVIC J
    Camptocormia, head drop and other bent spine syndromes: heterogeneous etiology and pathogenesis of parkinsonian deformities.
    Mov Disord. 2010;25:527-8.
    PubMed     Text format     Related articles   



  527. STOESSL AJ
    Scans without evidence of dopamine deficiency: the triumph of careful clinical assessment.
    Mov Disord. 2010;25:529-30.
    PubMed     Text format     Related articles   



  528. ADLER CH , Connor DJ, Hentz JG, Sabbagh MN, et al
    Incidental Lewy body disease: clinical comparison to a control cohort.
    Mov Disord. 2010;25:642-6.
    PubMed     Text format     Related articles    Abstract available



  529. SPANAKI C , Zafeiris S, Plaitakis A
    Levodopa-aggravated lateral flexion of the neck and trunk as a delayed phenomenon of unilateral pallidotomy.
    Mov Disord. 2010;25:655-6.
    PubMed     Text format     Related articles   



  530. GIERTHMUHLEN J , Arning P, Binder A, Herzog J, et al
    Influence of deep brain stimulation and levodopa on sensory signs in Parkinson's disease.
    Mov Disord. 2010.
    PubMed     Text format     Related articles    Abstract available



  531. NAKAMURA T , Hirayama M, Yamashita F, Uchida K, et al
    Lowered cardiac sympathetic nerve performance in response to exercise in Parkinson's disease.
    Mov Disord. 2010.
    PubMed     Text format     Related articles    Abstract available



  532. LEE MS , Lyoo CH, Choi YH
    Primary progressive freezing gait in a patient with CO-induced parkinsonism.
    Mov Disord. 2010.
    PubMed     Text format     Related articles   



  533. ALONSO-CANOVAS A , Katschnig P, Tucci A, Carecchio M, et al
    Atypical parkinsonism with apraxia and supranuclear gaze abnormalities in type 1 Gaucher disease. Expanding the spectrum: Case report and literature review.
    Mov Disord. 2010.
    PubMed     Text format     Related articles   



  534. RITZ B , Manthripragada AD, Qian L, Schernhammer E, et al
    Statin use and Parkinson's disease in Denmark.
    Mov Disord. 2010.
    PubMed     Text format     Related articles    Abstract available



  535. HAAXMA CA , Bloem BR, Overeem S, Borm GF, et al
    Timed motor tests can detect subtle motor dysfunction in early Parkinson's disease.
    Mov Disord. 2010.
    PubMed     Text format     Related articles    Abstract available



  536. MIZUNO Y , Hasegawa K, Kondo T, Kuno S, et al
    Clinical efficacy of istradefylline (KW-6002) in Parkinson's disease: A randomized, controlled study.
    Mov Disord. 2010.
    PubMed     Text format     Related articles    Abstract available



  537. ALLEN NE , Canning CG, Sherrington C, Lord SR, et al
    The effects of an exercise program on fall risk factors in people with Parkinson's disease: A randomized controlled trial.
    Mov Disord. 2010.
    PubMed     Text format     Related articles    Abstract available



  538. POORKAJ P , Raskind WH, Leverenz JB, Matsushita M, et al
    A novel X-linked four-repeat tauopathy with Parkinsonism and spasticity.
    Mov Disord. 2010.
    PubMed     Text format     Related articles    Abstract available



  539. LAI SC , Jung SM, Grattan-Smith P, Sugo E, et al
    Neuronal intranuclear inclusion disease: Two cases of dopa-responsive juvenile parkinsonism with drug-induced dyskinesia.
    Mov Disord. 2010.
    PubMed     Text format     Related articles    Abstract available



    March 2010
  540. VAN ROODEN SM , Heiser WJ, Kok JN, Verbaan D, et al
    The identification of Parkinson's disease subtypes using cluster analysis: A systematic review.
    Mov Disord. 2010;25:969-978.
    PubMed     Text format     Related articles    Abstract available



  541. LEWITT PA , Gostkowski MT
    "Sensory trick" in hemichorea-hemiballism and in Parkinson's disease tremor.
    Mov Disord. 2010.
    PubMed     Text format     Related articles   



  542. POLETTI M , Frosini D, Lucetti C, Dotto PD, et al
    Decision making in de novo Parkinson's disease.
    Mov Disord. 2010.
    PubMed     Text format     Related articles    Abstract available



  543. GOETZ CG , Stebbins GT, Chmura TA, Fahn S, et al
    Teaching program for the movement disorder society-sponsored revision of the Unified Parkinson's Disease Rating Scale: (MDS-UPDRS).
    Mov Disord. 2010.
    PubMed     Text format     Related articles    Abstract available



  544. HUOT P , Johnston TH, Darr T, Hazrati LN, et al
    Increased 5-HT(2A) receptors in the temporal cortex of parkinsonian patients with visual hallucinations.
    Mov Disord. 2010.
    PubMed     Text format     Related articles    Abstract available



  545. ROSENTHAL E , Brennan L, Xie S, Hurtig H, et al
    Association between cognition and function in patients with Parkinson disease with and without dementia.
    Mov Disord. 2010.
    PubMed     Text format     Related articles    Abstract available



  546. FANG F , Xu Q, Park Y, Huang X, et al
    Depression and the subsequent risk of Parkinson's disease in the NIH-AARP Diet and Health Study.
    Mov Disord. 2010.
    PubMed     Text format     Related articles    Abstract available



  547. IACOVELLI E , Gilio F, Meco G, Fattapposta F, et al
    Bladder symptoms assessed with overactive bladder questionnaire in Parkinson's disease.
    Mov Disord. 2010.
    PubMed     Text format     Related articles    Abstract available



  548. VIRUES-ORTEGA J , Rodriguez-Blazquez C, Micheli F, Carod-Artal FJ, et al
    Cross-cultural evaluation of the modified Parkinson Psychosis Rating Scale across disease stages.
    Mov Disord. 2010.
    PubMed     Text format     Related articles    Abstract available



  549. BONANNI L , Thomas A, Onofrj M
    Paradoxical kinesia in parkinsonian patients surviving earthquake.
    Mov Disord. 2010.
    PubMed     Text format     Related articles   



  550. COLOSIMO C , Martinez-Martin P, Fabbrini G, Hauser RA, et al
    Task force report on scales to assess dyskinesia in Parkinson's disease: Critique and recommendations.
    Mov Disord. 2010.
    PubMed     Text format     Related articles    Abstract available



  551. WINQUIST A , Steenland K, Shankar A
    Higher serum uric acid associated with decreased Parkinson's disease prevalence in a large community-based survey.
    Mov Disord. 2010.
    PubMed     Text format     Related articles    Abstract available



  552. JOHNSTON TH , van der Meij A, Brotchie JM, Fox SH, et al
    Effect of histamine H(2) receptor antagonism on levodopa-induced dyskinesia in the MPTP-macaque model of Parkinson's disease.
    Mov Disord. 2010.
    PubMed     Text format     Related articles    Abstract available



  553. KU S , Glass GA
    Age of Parkinson's disease onset as a predictor for the development of dyskinesia.
    Mov Disord. 2010.
    PubMed     Text format     Related articles    Abstract available



  554. COLETTI MOJA M
    Hiccups associated with non-ergoline dopamine agonists in Parkinson's disease.
    Mov Disord. 2010.
    PubMed     Text format     Related articles   



  555. ZIEGLER K , Schroeteler F, Ceballos-Baumann AO, Fietzek UM, et al
    A new rating instrument to assess festination and freezing gait in Parkinsonian patients.
    Mov Disord. 2010.
    PubMed     Text format     Related articles    Abstract available



  556. UHRIKOVA Z , Ruzicka E, Hlavac V, Nugent CD, et al
    TremAn: a tool for measuring tremor frequency from video sequences.
    Mov Disord. 2010;25:504-6.
    PubMed     Text format     Related articles   



  557. SHIN CW , Kim HJ, Park SS, Kim SY, et al
    Two Parkinson's disease patients with alpha-synuclein gene duplication and rapid cognitive decline.
    Mov Disord. 2010.
    PubMed     Text format     Related articles   



  558. MADDEN MB , Hall DA
    Shoulder pain in Parkinson's disease: A case-control study.
    Mov Disord. 2010.
    PubMed     Text format     Related articles   



  559. MERELLO M , Fantacone N, Balej J
    Kinematic study of whole body center of mass position during gait in Parkinson's disease patients with and without festination.
    Mov Disord. 2010.
    PubMed     Text format     Related articles    Abstract available



  560. SHIN HW , Chang JW, Kang SY, Sohn YH, et al
    Effects of chronic subthalamic stimulation on intractable akathisia in Parkinson's disease.
    Mov Disord. 2010.
    PubMed     Text format     Related articles   



  561. MONTASTRUC JL , Charlotte Danton A, Durrieu G, Lacroix I, et al
    Neuropathy as a potential complication of levodopa use in Parkinson's disease: A Pharmacological and Pharmacovigilance point of view.
    Mov Disord. 2010.
    PubMed     Text format     Related articles   



  562. ZHAO YJ , Wee HL, Chan YH, Seah SH, et al
    Progression of Parkinson's disease as evaluated by Hoehn and Yahr stage transition times.
    Mov Disord. 2010.
    PubMed     Text format     Related articles    Abstract available



  563. DALAKER TO , Zivadinov R, Larsen JP, Beyer MK, et al
    Gray matter correlations of cognition in incident Parkinson's disease.
    Mov Disord. 2010.
    PubMed     Text format     Related articles    Abstract available



  564. UNGER MM , Hattemer K, Moller JC, Schmittinger K, et al
    Real-time visualization of altered gastric motility by magnetic resonance imaging in patients with Parkinson's disease.
    Mov Disord. 2010.
    PubMed     Text format     Related articles    Abstract available



  565. CHUNG KA , Lobb BM, Nutt JG, McNames J, et al
    Objective measurement of dyskinesia in Parkinson's disease using a force plate.
    Mov Disord. 2010.
    PubMed     Text format     Related articles    Abstract available



  566. MORO E , Lozano AM, Pollak P, Agid Y, et al
    Long-term results of a multicenter study on subthalamic and pallidal stimulation in Parkinson's disease.
    Mov Disord. 2010.
    PubMed     Text format     Related articles    Abstract available



  567. DIEM-ZANGERL A , Seppi K, Oberaigner W, Poewe W, et al
    Mortality in Parkinson's disease, a 20-year follow-up study.
    Mov Disord. 2010.
    PubMed     Text format     Related articles   



  568. CARTER JH , Lyons KS, Stewart BJ, Archbold PG, et al
    Does age make a difference in caregiver strain? Comparison of young versus older caregivers in early-stage Parkinson's disease.
    Mov Disord. 2010.
    PubMed     Text format     Related articles    Abstract available



  569. FRAZZITTA G , Maestri R, Bertotti G, Uccellini D, et al
    Rehabilitation in Parkinson's disease: Assessing the outcome using objective metabolic measurements.
    Mov Disord. 2010.
    PubMed     Text format     Related articles    Abstract available



  570. MANNI R , Terzaghi M, Repetto A, Zangaglia R, et al
    Complex paroxysmal nocturnal behaviors in Parkinson's disease.
    Mov Disord. 2010.
    PubMed     Text format     Related articles    Abstract available



  571. DIEDERICH NJ , Pieri V, Hipp G, Rufra O, et al
    Discriminative power of different nonmotor signs in early Parkinson's disease. A case-control study.
    Mov Disord. 2010.
    PubMed     Text format     Related articles    Abstract available



  572. BRONZOVA J , Sampaio C, Hauser RA, Lang AE, et al
    Double-blind study of pardoprunox, a new partial dopamine agonist, in early Parkinson's disease.
    Mov Disord. 2010.
    PubMed     Text format     Related articles    Abstract available



  573. WOLF E , Seppi K, Katzenschlager R, Hochschorner G, et al
    Long-term antidyskinetic efficacy of amantadine in Parkinson's disease.
    Mov Disord. 2010.
    PubMed     Text format     Related articles    Abstract available



  574. AMBONI M , Barone P, Picillo M, Cozzolino A, et al
    A two-year follow-up study of executive dysfunctions in Parkinsonian patients with freezing of gait at on-state.
    Mov Disord. 2010.
    PubMed     Text format     Related articles   



  575. HELLMANN MA , Melamed E, Steinmetz AP, Djaldetti R, et al
    Unilateral lower limb rest tremor is not necessarily a presenting symptom of Parkinson's disease.
    Mov Disord. 2010.
    PubMed     Text format     Related articles    Abstract available



  576. STEPHANI C , Trenkwalder C
    Rhabdomyolysis after low-dose quetiapine in a patient with Parkinson's disease with drug-induced psychosis: A case report.
    Mov Disord. 2010.
    PubMed     Text format     Related articles   



  577. LI JY , Englund E, Widner H, Rehncrona S, et al
    Characterization of Lewy body pathology in 12- and 16-year-old intrastriatal mesencephalic grafts surviving in a patient with Parkinson's disease.
    Mov Disord. 2010.
    PubMed     Text format     Related articles    Abstract available



  578. NAISMITH SL , Shine JM, Lewis SJ
    The specific contributions of set-shifting to freezing of gait in Parkinson's disease.
    Mov Disord. 2010.
    PubMed     Text format     Related articles    Abstract available



    February 2010
  579. ROCHESTER L , Rafferty D, Dotchin C, Msuya O, et al
    The effect of cueing therapy on single and dual-task gait in a drug naive population of people with Parkinson's disease in northern Tanzania.
    Mov Disord. 2010.
    PubMed     Text format     Related articles    Abstract available



  580. SANCHEZ-CASTANEDA C , Rene R, Ramirez-Ruiz B, Campdelacreu J, et al
    Frontal and associative visual areas related to visual hallucinations in dementia with Lewy bodies and Parkinson's disease with dementia.
    Mov Disord. 2010.
    PubMed     Text format     Related articles    Abstract available



  581. NORD M , Zsigmond P, Kullman A, Arstrand K, et al
    The effect of peripheral enzyme inhibitors on levodopa concentrations in blood and CSF.
    Mov Disord. 2010;25:363-7.
    PubMed     Text format     Related articles    Abstract available



  582. RASCOL O , Azulay JP, Blin O, Bonnet AM, et al
    Orodispersible sublingual piribedil to abort OFF episodes: a single dose placebo-controlled, randomized, double-blind, cross-over study.
    Mov Disord. 2010;25:368-76.
    PubMed     Text format     Related articles    Abstract available



  583. TOTH C , Suchowersky O, Zochodne D
    Reply: Neuropathy as a potential complication of levodopa use in Parkinson's disease: A pharmacological and pharmacovigilance point of view.
    Mov Disord. 2010.
    PubMed     Text format     Related articles   



  584. PAGONABARRAGA J , Kulisevsky J, Llebaria G, Garcia-Sanchez C, et al
    PDD-Short Screen: A brief cognitive test for screening dementia in Parkinson's disease.
    Mov Disord. 2010.
    PubMed     Text format     Related articles    Abstract available



  585. SCIGLIANO G , Ronchetti G, Girotti F
    Plasma cholesterol and Parkinson's disease: Is the puzzle only apparent?
    Mov Disord. 2010.
    PubMed     Text format     Related articles   



  586. NAITO Y , Matsuo K, Kokubo Y, Narita Y, et al
    Higher-dose glutathione therapy for Parkinson's disease in Japan: Is it really safe?
    Mov Disord. 2010.
    PubMed     Text format     Related articles   



  587. SCHWINGENSCHUH P , Ruge D, Edwards MJ, Terranova C, et al
    Distinguishing SWEDDs patients with asymmetric resting tremor from Parkinson's disease: A clinical and electrophysiological study.
    Mov Disord. 2010.
    PubMed     Text format     Related articles    Abstract available



  588. YU RL , Wu RM, Tai CH, Lin CH, et al
    Feeling-of-knowing in episodic memory in patients with Parkinson's disease with various motor symptoms.
    Mov Disord. 2010.
    PubMed     Text format     Related articles    Abstract available



  589. O'SULLIVAN SS , Djamshidian A, Evans AH, Loane CM, et al
    Excessive hoarding in Parkinson's disease.
    Mov Disord. 2010.
    PubMed     Text format     Related articles    Abstract available



  590. SUN QY , Guo JF, Wang L, Yu RH, et al
    Glucocerebrosidase Gene L444P mutation is a risk factor for Parkinson's disease in Chinese population.
    Mov Disord. 2010.
    PubMed     Text format     Related articles    Abstract available



  591. BARTOLO M , Serrao M, Tassorelli C, Don R, et al
    Four-week trunk-specific rehabilitation treatment improves lateral trunk flexion in Parkinson's disease.
    Mov Disord. 2010.
    PubMed     Text format     Related articles    Abstract available



  592. KATAOKA H , Inoue M, Ueno S
    Background scenery visual hallucinations in a depressed patient with Parkinson's disease.
    Mov Disord. 2010.
    PubMed     Text format     Related articles   



  593. IIJIMA M , Osawa M, Momose M, Kobayakawa T, et al
    Cardiac sympathetic degeneration correlates with olfactory function in Parkinson's disease.
    Mov Disord. 2010.
    PubMed     Text format     Related articles    Abstract available



  594. DAVIS KL , Edin HM, Allen JK
    Prevalence and cost of medication nonadherence in Parkinson's disease: Evidence from administrative claims data.
    Mov Disord. 2010.
    PubMed     Text format     Related articles    Abstract available



  595. ELBLE RJ , Suchowersky O, Shaftman S, Weiner WJ, et al
    Impact of belief in neuroprotection on therapeutic intervention in Parkinson's disease.
    Mov Disord. 2010.
    PubMed     Text format